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INTRODUCTION 
Malignant catarrhal fever (MCF) is an acute viral disease of domestic 
and exotic ruminants. It has a wor ldwide distribution and i s generally a 
s poradic disease with low morbidity and high mor tality (Plowright, 1968) . 
Historically, MCF has been separated into two epidemiological forms, a 
s heep -goat -associated form and a wildebeest- de rived form based on 
reservoir host and ease of experimental transmission (Daubney and Hudson, 
1936). On a clinicopathologic basis the two forms are indis t inguishable 
(Goetze and Liess, 1930 , cited by Daubney and Hudson, 1936). The 
etiological agent for the sheep-goat-associated form has not been 
determined. Based on serological evidence, Rossiter ( 1983) hypothesized 
t he causative agent to b e a cell-associated herpesvirus antigenically 
related to the cell-associated herpesvirus, alcelaphine herpesvirus- 1 
(AHV - 1) , which is the etiological agent for t h e wildebeest-derived form of 
MCF (Plowright et al., 1960). 
Malignant catarrhal fever is classified as an exotic disease even 
though both forms of t h e disease have been diagnosed in the United States. 
Accurate diagnosis of exotic diseases is critical to the protection of our 
domestic livestock. Diagnosis on a clinical basis is not reliable, as MCF 
resembles other viral diseases including infectious bovine 
rhinotracheitis, bovine virus diarrhea- mucosal disease, bluetongue, 
vesicular stomatitis , and rinderpest (Heuschele and Castro, 1984). Gross 
pathologiclesions are not dis tinctive (Jubb et al., 1985). 
Histopathological diagnosis of MCF is considered reliable due to the 
presence of characteristic l esions consisting of a disseminated fibrinoid 
2 
vasculitis with adventitial accumulation of primarily mononuclear cells in 
virtually all cases of the disease (Jubb et al . , 1985). Standard virus 
isolation techniques are not practical due to the cell-associated nature 
of the virus. Viral infectivity depends on the maintenance of tissue cell 
viability, which is destroyed by freezing and post mortem autolysis 
(Piercy, 1953) . Low tissue viral antigen levels (Rossiter, 1980a; 
Rossiter, 1980b; Patel and Edington, 1980) makes diagnosis of MCF using 
electron microscopy for detection of virions or immunofluorescence on 
frozen sections of tissue unreliable. 
In order to provide laboratory diagnostic assistance for MCF 
diagnosis, studies were initiated to compare serologic assays for 
detection of antibodies to MCF virus. Three serologic assays , the 
indirect immunofluorescence assay (IFA), the virus neutralization assay 




In the Masai Reserve of Kenya and Tanzania, the Masai were the first 
to recognize a connection between wildebeest and a disease in cattle, 
"snotsiekte", which occurs annually during the wildebeest calving season. 
The Masai believe cattle become infected from grazing pastures 
contaminated by wildebeest after-birth or hair shed by young wildebeest 
calves (Daubney and Hudson, 1936). 
In South Africa, Mettam, in 1923, published the first description of 
"snotsiekte" which he believed was a separate clinical entity from the 
disease in European cattle known as malignant catarrh (cited by Daubney 
and Hudson, 1936). "Snotsiekte" occurred in cattle grazing common 
pastures with wildebeest which he hypothesized served as reservoir hosts 
for the etiological agent. Transmission of "snotsiekte" from a black 
wildebeest (Connochaetes gnou) to a calf by injection of whole blood 
substantiated this hypothesis. Mettam, 1923, was the first to transmit 
"snotsiekte" between cattle by inoculation of large volumes of fresh 
blood. He suggested that blood-sucking vectors might play a role in the 
natural transmission of the disease, but was unsuccessful in his attempts 
to transmit the disease using cattle lice or wildebeest lice. Contact 
spread between cattle did not occur (cited by Daubney and Hudson, 1936) . 
In Hannover, Germany, research on malignant catarrh, a clinical 
entity recognized in Europe for over one hundred years, was stimulated by 
Dobberstein's findings in 1925 of characteristic infiltrative lesions in 
the brain of cattle dying from the disease (cited by Daubney and Hudson, 
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1936) . Glamser, 1926, confirmed Dobberstein's observation. Goetze and 
Liess, in 1929, successfully transmitted malignant catarrh between cattle 
by inoculation of fresh blood, but failed to transmit the disease with 
brain , aqueous humor, or lymphatic tissue. Natural transmission was 
suggested to occur via blood-sucking vectors, but attempts to transmit the 
disease with cattle lice by Goetze and Liess, 1929, and sheep keds by 
Goetze, 1930, were unsuccessful (cited by Daubney and Hudson, 1936). 
Goetze and Liess, 1929, could not demonstrate direct contact spread 
between cattle (cited by Daubney and Hudson, 1936). Transmission of the 
disease in cattle by blood inoculation was successful 40% of the time with 
incubation periods of 16 days to 10 months. The disease was not 
transmitted by filtered blood, centrifuged blood or blood collected more 
than a few hours before animal inoculation . Goetze and Liess, in 1929, 
failed to transmit the disease to mice, rats , guinea pigs, cats, dogs.and 
pigs (cited by Daubney and Hudson, 1936). Based on epidemiological 
evidence, Goetze and Liess, 1929, proposed sheep to be the reservoir host 
for malignant catarrh . Goetze, in 1930, suggested transmission to cattle 
in contact with placental or uterine discharge from lambing ewes (cited 
Daubney and Hudson, 1936). 
Quinlan, who was in Hannover, Germany, during the transmission 
studies of Goetze and Liess drew their attention to the similarities 
between malignant catarrh and Mettam's findings on "snotsiekte" (cited by 
Daubney and Hudson, 1936). After reviewing Mettam's publication, Goetze 
and Liess, 1929 , concluded that "snotsiekte" and malignant catarrh were a 
single clinical entity (cited by Daubney and Hudson, 1936). This view was 
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supported by Daubney and Hudson (1936) with the results they were 
obtaining from experimental transmission with both forms of the disease . 
Researchers have continued to separate the disease, now referred to as 
malignant catarrhal fever (MCF) , into two epidemiological forms , the 
sheep-goat-associated form and the wildebeest-derived form based on 
reservoir host and ease of experimental transmission. Experimental 
transmission of MCF has been reported by many investigators (Appendix I ). 
Etiology 
The etiological agent for the sheep-goat-associated form has not been 
identified . It is hypothesized , based on serological evidence, to be a 
cell-associated herpesvirus antigenically related to the AHV - 1 viruses 
(Rossiter, 1983) . A cell -associated herpesv irus was isolated from a 
clinical case of sheep-goat-associated MCF (Hamdy et al., 1978), but the 
isolate failed to induce clinical disease characteristic of MCF in cattle. 
A cytotoxic lymphoblastoid cell line (MF120) has been established from 
mesenteric lymph node cells of a rabbit (57th serial passage) with 
experimental sheep-goat-associated MCF (Reid et al . , 1983) . The MF120 
cells have the morphology and functional characteristics of large granula r 
lymphocytes (LGL). Intravenous inoculation of rabbits with as few as 102 
of these cells induced MCF-like clinical disease (Reid et al . , 1983). 
Viability of the LGL cells was critical to successful disease transmision 
suggesting a cell-associated etiological agent . No etiological agent has 
been identified in these c e lls using indirect immunofluorescence or 
electron microscopy (Reid et al . , 1983) . Other LGL cell lines have been 
isolated from tissues of cattle and deer with sheep-goat-associated MCF, 
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and from rats experimentally infected with wildebeest-derived MCF (Reid 
and Buxton, 1985). None of the other LGL cell lines have induced clinical 
disease in cattle, deer or rabbits. The use of molecular virologic 
techniques may be necessary to identify the causative agent (Heuschele et 
al., 1984a; Harkness, 1985; Plowright, 1986). 
Development of primary bovine thyroid (BTh) cell cultures by 
Plowright and Ferris (cited by Plowright et al., 1960) made isolation of 
the etiological agent for the wildebeest-derived form possible. Prior to 
this , cattle inoculation was the only means for identification and 
maintenance of MCF isolates. Bovine thyroid cutures have equal 
sensitivity to cattle inoculation for MCF isolation (Plowright, 1968). 
The etiological agent for the wildebeest-derived form was first 
isolated in BTh cultures from heparinized whole blood of blue wildebeest 
(Plowright et al., 1960). The agent was described as a filterable virus 
which would pass through a 300nm filter, but not a 275nm filter. The 
isolate was ether and chloroform senstive. Infectivity of the virus was 
inhibited by 5-iodo-2'-deoxyuridine. Electron microscopy revealed the 
virus to be a herpesvirus with lOOnm nucleocapsids, and 140 to 240nm 
enveloped virions. Viral cytopathic effects (cpe) were characterized by 
the formation of small multinucleated, often vacuolated, syncytia. The 
isolate induced clinical disease characteristic of MCF in cattle with a 
mean incubation period of 20 days. Reisolation of the virus from infected 
cattle fulfilled Koch's postulates for identification of etiological 
agents (Plowright et al., 1963; Plowright, 1964). This established 
wildebeest as reservoir hosts for MCF. 
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Studies were initiated to determine the means of virus maintenance in 
wildebeest, and the natural modes of transmission from wildebeest to 
cattle (Plowright, 1965a ; Plowright, 1965b). Plowright (1965a) detected 
viremia in 31% of wildebeest calves less than three months of age. 
Isolation of virus from a wildebeest fetal spleen, and from wildebeest 
calves less than one week of age suggested congenital transmission as a 
mode of virus maintenance in the wildebeest (Plowright, 1965a; Plowright, 
1965b). Horizontal spread between wildebeest calves, and between 
wildebeest calves and cattle occurred with exposure to wildebeest calves 
less than three months of age which had persistent high level viremia 
(Plowright, 1965a; Plowright, 1965b). Contact spread rarely occurred with 
exposure to wildebeest calves over three months of age (Mushi et al . , 
198lc). Rweyemamu et al., in 1974, were the first to isolate MCF virus 
from the nasal secretions of wildebeest (cited by Mushi et al., 1980b). 
Mushi et al. (1980b) demonstrated that wildebeest calves less than three 
months of age shed cell-free virus in their nasal and ocular secretions. 
Viral shedding appeared to cease at approximately three months of age with 
the development of neutralizing antibodies in the nasal secretions (Mushi 
et al., 1980b). Mushi et al. (198lc) hypothesized inhalation or ingestion 
of cell-free virus-laden droplets produced by the snorting of young 
wildebeest calves as the mode of natural transmission to wildebeest calves 
and cattle. Virus shed in the nasal and ocular secretions of infected 
cattle was cell-associated (Mushi and Rurangirwa, 198lc) which would 
account for the lack of contact spread between cattle. 
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Reid and Rowe (1973) isolated a MCF-like virus (K/30) from a Cokes 
hartebeest (Alcelaphus buselaphus cokei). This isolate induced clinical 
disease characteristic of MCF in cattle. A cell-associated MCF-like virus 
was isolated from topi (Damaliscus lunatus korri&um) using topi cell 
cultures (Mushi et al., 198la). This isolate failed to induce clinical 
disease in cattle or rabbits. 
The terminology alcelaphine herpesvirus (AHV) was proposed by Reid et 
al. (1975) based on the classification of reservoir host species 
(wildebeest, topi, and hartebeest) as members of the subfamily 
Alcelaphinae . The designation of AHV-1 for wildebeest isolates, and AHV-2 
for topi and hartebeest isolates has recently been proposed (cited by 
Heuschele and Castro, 1984). The AHV viruses have been further classified 
as members of the subfamily Gammaherpesvirinae based on the lymphotropism 
of the virus, latency, abscence of in vivo inclusion bodies, but 
development of Cowdry type A inclusion bodies and syncytia in cell 
cultures, and the highly variable incubation period (Heuschele, 1984). 
Restriction endonuclease profiles of AHV-1 isolates demonstrated this 
group of viruses to be distinct from other bovine herpesviruses (Osorio et 
al., 1985) . 
Pathogenesis 
The exact pathogenesis for MCF has not been determined. Plowright 
(1968) suggested an immune mediated hypersensitivity to the AHV -1 virus. 
Rweyemamu et al . (1976) described MCF as an immune complex disease 
with circulating immune complexes comprised of AHV-1 infected lymphocytes 
or lymphocytes expressing virus induced plasma membrane antigens, specific 
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anti-AHV-1 immunoglobulins, and complement. Deposition of circulating 
immune complexes in blood vessel walls was hypothesized to cause Arthus 
type III vasculitis typical of immune complex diseases (Rweyemamu et al., 
1976). Arthus type III vasculitis was also proposed as the basis for the 
pathogenesis of the sheep - goat -associate d MCF (Selman et al., 1974). Many 
researchers have attempted to demonstrate immune complexes in MCF lesions 
in both cattl e and rabbi ts with little success (Liggitt and DeMartini, 
1980 ; Mushi and Rurangirwa, 198lb; Patel and Edington , 1982b ). Patel and 
Edington (1982a) used a n ti-AHV- 1 I gG (F(ab)z) fragments to demonstrate 
virus induced antigens on the surface of lymphocytes expressing 
intracellular viral antigens by indirect immunofluorescence. They were 
unable to determine when in the virus replication cycle the surface 
an tigens were produced or if latently infected cells expressed surface 
an tigens. Patel and Edington (1982a) detected antibodies against the 
surface antigens in terminal sera of cattle and rabbits infected with 
AHV -1 vi rus . Attachment of these antibodies to the lymphocyte surface 
antigens did not result in immune cytol ysis. When bovine, human , or 
guinea pig complement was added to the resulting antigen -antibody complex , 
immune cytol ysis occurred. Rabbit complement did not cause immune 
cytolys i s. Patel and Edington (1982a) from this work hypothesized that 
complement played an important ro l e in MCF pathogenesis. Using indirect 
immunofluorescence, Patel and Edington (1982b) were able to demonstra te 
deposits of IgG-C(3b)-conglutinin (Cg) in renal arteries and glomeruli of 
AHV-1 infected cattl e, but the complexes were not always associated with 
histologic l esions. Patel and Edington (1982b) were unable to demonstrate 
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viral antigens or AHV-1 specific immunoglobulins in any of the deposits. 
Only rarely could AHV-1 infected lymphocytes be detected in vascular 
lesions by indirect immunofluorescence. Clinically affected cattle were 
shown to have decreased conglutinin and complement (C3) levels in the 
terminal stages of disease (Patel and Edington, 1982b). Patel and 
Edington (1982b) were unable to demonstrate virus induced transformation 
of lymphoid cells. Mushi and Rurangirwa (198lb) also found a 25-35% 
decrease in serum C3 levels of cattle with terminal stage MCF. No change 
was detected in serum levels of hemolytic complement, IgM, IgG1 1 or IgG2. 
Mushi and Rurangirwa (198lb) demonstrated C3 glomerular deposits by 
indirect immunofluorescence, but couldn't demonstrate AHV-1 specific 
immune complexes in vascular lesions or in circulation. Rabbits 
hyperimrnunized with a virulent AHV-1 developed high titers of neutralizing 
antibodies, but were still susceptible to virulent AHV-1 challenge 
suggesting that serum antibodies do not play an important role in 
pathogenesis of the disease (Rurangirwa and Mushi, 1984). Based on these 
findings, Mushi and Rurangirwa (198lb) hypothesized that MCF was not a 
immune complex mediated disease, but had a cell-mediated immunopathologic 
(CMI) basis. 
Further evidence for CMI pathogenesis was demonstrated by Mushi and 
Rurangirwa (198ld) with their work on delayed hypersensitivity (DTH) skin 
testing in AHV-1 experimentally infected rabbits. Intradermal injection 
of homologous virus antigen produced DTH nodules by 24 hours 
post-inoculation . Maximal DTH response occurred after 48 hours in rabbits 
injected during the seventh day of AHV - 1 infection . Delayed 
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hypersensitivity did not occur in rabbits injected after the onset of 
pyrexia. Mushi and Rurangirwa (198ld) hypothesized that this failure of 
DTH resulted from AHV induced T-lymphocyte dysfunction or suppression of 
the cell-mediated immune system. Rurangirwa and Mushi (1982a) found 
decreased antibody response to sheep red blood cells (SRBC) in AHV-1 
infected rabbits when they were inoculated with SRBC during the third to 
tenth day post AHV-1 infection. Parallel decreases in AHV-1 specific 
antibody was not seen. Since antibody production to SRBC requires 
B-lymphocytes, T-lymphocytes, and macrophage interaction, they 
hypothesized that the decreased antibody formation was related to 
T-lymphocyte dysfunction occurring between the second and fourth day of 
AHV-1 infection. Normal antibody production to the AHV-1 virus suggests 
that humoral initiation occurs before the T-lymphocyte dysfunction. 
Rurangirwa and Mushi (1984) treated rabbits with cyclophosphamide, which 
has a mitostatic effect on B-lymphocytes, before and during AHV-1 
infection. The treated rabbits had milder lymphadenopathy, slower viremia 
development, delayed virus neutralization (VN) antibody response, and 
prolonged clinical disease with intermittent pyrexia. The mean incubation 
period of treated rabbits was not significantly different from the mean of 
control rabbits. This was taken as further evidence for a CMI 
pathogenesis. 
Liggitt and DeMartini (1980) suggested a CMI reaction of the vascular 
endothelium similar to graft rejection or direct viral induced cytolysis 
for the pathogenesis of MCF. Viral cpe could not be demonstrated in 
tissues of animals infected with AHV-1 (Plowright et al., 1960; Straver 
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and Van Bekkum, 1979; Rossiter, 1980a). Buxton et al . (1984) could not 
demonstrate viral cpe or antigens in tissues of rabbits experimentally 
infected with sheep-goat-associated MGF. 
Hunt and Billups (1979) described AHV-1 as a oncogenic herpesvirus. 
They hypothesized that the viral DNA was incorporated into the genome of 
infected lymphocytes or existed as episomal DNA causing lymphocyte 
transformation . This hypothesis was based on several factors, including 
lack of viral cpe in lesions, rare detection of viral antigen in tissues, 
the cell-associated nature of the virus, failure of contact spread between 
cattle, and the presence of Gowdry type A inclusions and viral cpe in cell 
culture systems similar to that seen with H. saimiri, H. ateles, Marek's 
disease virus, and Epstein-Barr virus. Virus induced transformation of 
lymphoid cells causing dysfunction of T-suppressor cells with subsequent 
T-lymphocyte proliferation and B-lymphocyte cytolysis was also 
hypothesized by other investigators (Edington et al., 1979, cited by 
Buxton et al . , 1984; Denholm and Westbury, 1982). 
Reid and Buxton, in 1981, suggested a pathogenesis based on virus 
induced dysfunction of the imrnunoregulatory system from their results with 
serial tranmission studies of sheep-goat-associated MGF in rabbits (cited 
by Buxton et al., 1984) . Tissues from a red deer with 
sheep-goat-associated MGF were inoculated into rabbits inducing clinical 
disease suggestive of MGF (Buxton and Reid , 1980). The isolate was 
maintained by serial passages in rabbits using intravenous injection of 
washed lymph node cells (Buxton et al., 1984). Progression of lesions was 
studied. Lymphoid cell proliferation in the T-dependent areas of lymphoid 
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tissues and interstitial areas of non-lymphoid organs occurred from day 
three to day 13 post- infection, and was comprised of primarily 
T-lyrnphocytes (Buxton et al . , 1984) . Buxton et al. (1984) described the 
proliferation as hyperplasia since the structural architecture of the 
involved tissues remained unchanged . Cyclosporin A (20mg Kg- 1), a potent 
T- lyrnphocyte suppressor which prevents initiation of T-lyrnphocyte mediated 
immune reactions, was used in rabbits to demonstrate that suppression of 
the viral induced T-lymphocyte proliferation did not affect the incubation 
period, disease course, or development of tissue necrosis (Buxton et al., 
1984). Based on this evidence, they hypothesized MCF pathogenesis to 
involve virus induced dysfunction of a subpopulation of T-lyrnphocytes 
termed large granular lymphocytes (LGL). Mesenteric lymph node cells from 
a rabbit with sheep - goat -associated MCF (57th serial passage) were treated 
with polyethylene glycol to fuse them with fetal ovine kidney (FOK) cells 
(Reid et al., 1983). The resulting cell monolayers degenerated leaving 
single and small c l umps of lyrnphoblastoid cells (MF120) in the supernatant 
fluid. These cells had morphological and functional characteristics of 
LGL (rabbit karyotype) cells (Reid et al., 1983). The MF120 cells 
appeared very similar to lymphocytes generated from marmosets infected 
with H. ateles or H. saimiri suggesting a similar pathogenesis. Large 
granular lymphocytes could not be identified in MCF lesions (Reid et al., 
1983). High levels of natural killer cell (NKC) activity were detected in 
experimentally infected rabbits during clinical disease, but not during 
the incubation period (Reid and Buxton, 1985) . Rabbits, cattle, and deer 
with sheep-goat-associated MCF , and rats with wildebeest-derived MCF had 
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detectable levels of NKC activity (Reid and Buxton, 1985). Reid and 
Buxton (1985) hypothesized the LGL cells to be targeted by the MCF virus 
with integration of the viral DNA into the cell genome or existing as 
episomal DNA. They hypothesized that virus induced dysfunction of the LGL 
cells with subsequent production of interleukin-2 or other lymphokines was 
responsible for the benign polyclonal T-lymphocyte hyperplasia. Viral 
induced dysfunction of the NKC activity of the LGL cells with 
indiscriminant extension of NKC cytotoxicity to normal cells was 
hypothesized to be responsible for development of necrotic lesions, onset 
of clinical disease, and ultimately death (Buxton et al., 1984). This 
hypothesis for the pathogenesis of MCF could account for the long and 
variable incubation period, and the variable distribution and severity of 
histopathologic lesions seen with both epidemiological forms the disease 
(Reid and Buxton, 1985). 
Clinical Disease 
Goetze, in 1930, arbitrarily divided the sheep-goat-associated form 
into four clinical forms, namely, the peracute, the intestinal, the head 
and eye, and the mild form (cited by Daubney and Hudson, 1936). 
Considerable overlap occurs between the clinical forms. Daubney and 
Hudson (1936) observed that the wildebeest-derived form of MCF in cattle 
could be divided into the same clinical forms with the head and eye form 
being the most prevalent. 
Clinical signs in the peracute form r ange from acute death without 
clinical disease to a brief clinical illness of one to three days 
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characterized by hyperthermia, mucosal hyperemia, and hemorrhagic 
gastroenteritis (Heuschele and Castro, 1984; Jubb et al., 1985). 
The intestinal form is characterized by pyrexia, mucosal hyperemia, 
lacrimation, lymphadenopathy, and diarrhea generally ending in death 
within four to nine days (Heuschele and Castro, 1984; Jubb et al., 1985). 
The head and eye form is the typical clinical syndrome with a 
clinical course of seven to 18 days. Mortality is generally greater than 
95%. Pyrexia (104-1070F) with progressive serous, mucoid to purulent 
nasal and ocular discharges are classical signs of this form . Muzzle and 
nasal encrustation, often with secondary excoriation, leads to blockage of 
the nasal passages, dyspnea and open mouth breathing. Hyperemia of the 
oral mucosa with focal to diffuse necrosis involving the lips, gums, hard 
and soft palate causes increased salivation and drooling. Sloughing of 
the tips of the buccal papillae is frequently seen. Ophthalmia with 
lacrimation, photophobia, conjunctivitis, and centripetally progressive 
corneal opacity results in partial to complete blindness. Corneal opacity 
is generally bilateral, but can be unilateral. Hypopyon may be present. 
Enlarged superficial lymph nodes, especially of the head and neck, are 
present in most cases. Anorexia with constipation is generally present 
late in the clinical disease, but diarrhea has been observed during 
terminal stages. Central nervous signs can include muscle tremors, 
incoordination, and terminal nystagmus. Occasionally a generalized 
exanthema or laminitis has been noted (Heuschele and Castro, 1984) . 
The mild form is generally a nonfatal clinical episode characterized 
by mild to moderate pyrexia, lacrimation, muzzle encrustation, mucosal 
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hyperemia, and enlarged superficial lymph nodes. Clinical regression 
generally occurs over a three to nine day period (Kalunda, 1975) . 
Clinical signs in exotic ruminants, with the exception of members of 
the subfamily Bovinae, tend to be more subtle. Pyrexia, conjunctivitis, 
photophobia, moderate corneal opacity, serous nasal discharge, diarrhea, 
depression, and a variable lymphadenopathy are seen . Oral and nasal 
cavity inflammation is generally less severe than that seen in cattle 
(Heuschele and Castro, 1984). The peracute form was most commonly seen in 
deer (Reid et al., 1979; Denholm and Westbury , 1982). 
Clinical signs in experimentally infected rabbits include mucosal 
hyperemia, keratitis, catarrhal nasal and ocular discharges , depression, 
anorexia, incoordination, and frequently hind leg paralysis with loss of 
the ability to adduct the hind limbs (Daubney and Hudson , 1936). 
Malignant catarrhal fever can rarely be diagnosed on a clinical 
basis. Differential diagnoses would include bovine virus diarrhea-mucosal 
disease, bluetongue, rinderpest, vesicular stomatitis, foot and mouth 
disease, and ingestion of caustic chemicals, poisonous plants or 
mycotoxins (Heuschele and Castro, 1984). Clinical cases of MCF have been 
reported in a wide range of domestic and exotic ruminants (Appendix II ) . 
Gross Pathology 
The extent and severity of the gross lesions seen with MCF in cattle 
varies depending on the severity and clinical course of the disease (Jubb 
et al., 1985). 
Peracute cases have few lesions with the most consistent being a 
hemorrhagic gastroenteritis . In more prolonged forms, a variety of gross 
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lesions are seen. Condition of the carcass varies from normal to extreme 
dehydration and emaciation. A mucopurulent conjunctivitis with unilateral 
or bilateral corneal opacity is frequently noted. Encrustation of the 
muzzle and nares with secondary excoriation is often seen. Skin hyperemia 
especially in the unpigmented regions is common. Occasionally a 
generalized exanthema is observed. 
Respiratory tract lesions range from nasal mucosal hyperemia with 
mild serous discharge to severe inflammation and congestion of the mucosa 
of the nasal passages, turbinates, pharynx, and larynx with focal erosions 
and grayish yellow pseudomembranes. The tracheobronchial mucosa is 
generally hyperemic with petechiation or erosions. Lungs might appear 
normal or be edematous and emphysematous . Bronchopneumonia may complicate 
prolonged cases. 
Gastrointestinal tract lesions range from no visible lesions to 
severe hemorrhagic gastroenteritis. The most commonly seen lesions 
included mucosal inflammation with or without erosions in the oral cavity 
especially on the dental pad, around the base of the incisors, on the 
palate and the tongue. Erosion of the tips of the buccal papillae is a 
common finding. Petechial hemorrhages and focal erosions of the 
esophageal mucosa are occasionally observed. Hyperemia and congestion of 
the abomasal mucosa with scattered petechial hemorrhages and occasional 
erosions is commonly seen. Petechial hemorrhages and congestion of the 
mucosa with occasional erosions occurs in both the small and large 
intestines. Button ulcers in the jejunum and ileum of cattle with chronic 
cases of MCF have been described (Kalunda, 1975 ; Rweyemamu et al., 1976). 
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Lesions of the urinary system include hyperemia and congestion of the 
mucosa of the urinary bladder with petechial and ecchymotic hemorrhages. 
Occasionally more severe hemorrhage is associated with erosions of the 
epithelium of the urinary bladder. Kidneys may be normal in appearance or 
have small raised greyish-white foci in the capsular area of the renal 
cortex. Petechial and ecchymotic hemorhages are frequently present in the 
renal pelvis and ureteral mucosa. 
The liver is generally enlarged . A diffuse mottling with small white 
foci is especially prominent in the areas of the portal triads . The gall 
bladder wall is often thickened due to edema, and the mucosa frequently 
has petechial hemorrhages and erosions. 
Enlargement of lymph nodes and hemolymph nodes , especially of the 
head and neck, are characteristic lesions of MCF . Lymphocytic hyperplasia 
accounts for most of the increase in lymph node size. The spleen is 
generally enlarged with prominent Malpighian corpuscles (Jubb et al., 
1985). 
Petechial hemorrhages on the epicardium of the heart have been noted. 
Blood vessels, especially small arterioles, are prominent due to 
thickening of the vessel walls secondary to the vasculitis and 
infiltration of mononuclear cells (Heuschele and Castro, 1984). 
Gross lesions in rabbits experimentally infected with MCF are 
virtually identical to those in cattle with the exception of a much less 
marked lymphadenopathy (Heuschele and Castro, 1984). 
Exotic ruminants which die from MCF have gross lesions similar to 
cattle. The nasal and ocular discharges are generally l ess prominent and 
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remain serous in nature. Fewer erosive lesions of the nasal and oral 
cavities are generally seen (Heuschele and Castro, 1984). 
The marked variability of gross lesions makes diagnosis of MCF on a 
gross pathological basis unreliable. Histopathology is generally required 
to confirm a clinical diagnosis of MCF. 
Histopathology 
Diagnosis on a histopathological basis is considered reliable due to 
characteristic histologic changes present in virtually all cases of the 
disease. Vascular lesions consisting of a disseminated fibrinoid 
necrotizing vasculitis with mononuclear cell infiltration of the 
adventitia are present in small and medium sized arteries and arterioles 
(Jubb et al., 1985). The severity of the vasculitis and subsequent tissue 
necrosis increases with progression of the disease. The best tissues to 
examine for vascular lesions are the carotid rete, kidney, liver , adrenal 
capsule, brain, and leptomeninges (Jubb et al., 1985). 
All lymphoid tissues demonstrate follicular necrosis with loss of 
small mature lymphocytes and a concomitant increase in macrophages and 
proliferation of immature lymphoblasts. Infiltration and proliferation of 
mononuclear cells generally associated with blood vessels can be profuse 
forming raised white foci in many organs including the capsular area of 
the renal cortex and portal triad regions of the liver. 
A nonsuppurative meningoencephalitis is frequently seen secondary to 
vascular lesions. 
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Hyperemia, petechial hemorrhages, erosions and edema of the 
alimentary and respiratory tract mucosa occur secondary to the vascular 
l esions. 
Ophthalmitis involving all portions of the globe is frequently seen 
with MCF . Corneal edema and vasculariza tion occur secondary to vasculitis 
of the limbic vessels. Vasculitis of the retina frequently occurs with 
occasional hemorrhage and subsequent retinal detachment. 
Virus Isolation 
Permissive cell cultures for the isolation of the etiological agent 
of the sheep-goat-associated form have not been found. Efforts to isolate 
and characterize the causativ e agent continue . 
Virus isolation of AHV-1 and AHV-2 viruses from several different 
species has been accomplished (Appendix III) . Permissive cell cultures 
include, primary and secondary bovine thyroid cultures, embryonic bovine 
kidney cultures, bovine testes , fetal aoudad kidney, and mouflon kidney 
cultures (Plowright et al., 1960; Castro et al. , 1981; Plowright, 1986 ; 
Heuschele, 1982). Two cell-associated virus isolation techniques have 
been described . The first being cocultivation of infected tissue or huffy 
c oat leukocytes with permissive cell cultures (Plowright et al., 1960) , 
and the second a fusion technique using polyethylene glycol to fuse blood 
leukocytes with permissive cells (Castro et al., 1983). Tissues of choice 
for AHV virus isolation included whole uncoagulated blood (EDTA, heparin , 
or ACD solution) , spleen, lung, lymph nodes, adrenals, tonsils, thyroids, 
liver, and kidney (Plowright et al., 1960; Kalunda et al., 198la; Mebus et 
al., 1979). Tissues for virus isolation need to be collected wi t hin hours 
21 
of death, chilled to 4C, and processed as soon as possible to achieve 
virus isolation (Plowright, 1964). Viral infectivity in blood and tissues 
is completely cell-associated (Plowright, 1968). Freezing, 
lyophilization, or desiccation of infected blood and tissues destroys 
viral infectivity (Piercy, 1953). Early isolation attempts used a 37C 
incubation temperature. Under these conditions, typical viral cpe was 
observed in three to 21 days (Plowright et al., 1963) . Early viral 
passages were acomplished using cell-associated techniques. Plowright et 
al., 1965, noted a gradual change of viral cpe from syncytial formation to 
foci of rounded refractile cells with change of the virus from 
cell-associated to cell-free with serial passage in cell cultures (cited 
by Harkness and Jessett, 1981). 
Harkness and Jessett (1981) demonstrated a marked effect of 
incubation temperature on the growth characteristics of AHV-1 virus in 
bovine thyroid cultures. Incubation of infected cultures at 37C produced 
cell - associated virus with nonprogressive syncytial cpe which reached a 
maximal virus titer at nine days post-infection. While incubation of 
infected cultures at 32-34C produced virus which formed foci of rounded 
refractile cells two to three days later, and reached a maximal virus 
titer at 12 days post-infection. The 32-34C virus had measurable 
quantities of cell-free virus which accounts for the more progressive 
nature of the viral cpe. Reciprocal temperature shift experiments 
demonstrated that the type of viral cpe was directly related to incubation 
temperature. Harkness and Jessett (1981) hypothesized that incubation 
temperature influenced the accumulation of virus coded material at the 
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surface of the cells. Due to the more progressive nature of the cpe, and 
the enhanced production of cell-free virus, Harkness and Jessett (1981) 
suggested that all primary isolations should be done at a 32-34C 
incubation temperature. 
Viral isolates are identified on the basis of viral cpe (Plowright et 
al., 1960), direct or indirect immunofluorescence (Ferris et al., 1976), 
virus neutralization (Plowright, 1967), and electron microscopy (Castro 
and Daley, 1982; Castro et al., 1985). 
Heuschele and Fletcher (1984) described a direct immunofluorescence 
technique for detection of viral antigens in blood leukocytes from 
reservoir hosts and clinically affected animals. Whole blood or leukocyte 
smears were air dried, fixed in acetone, and stained using a direct anti-
AHV-1 conjugate (Heuschele et al., 1984b) produced from a seropositive 
whitebearded wildebeest antisera (VN 1:256) . Positive smears demonstrated 




Cell-associated WCll virus was isolated from a female blue wildebeest 
calf less than one week of age in primary BTh cultures (Plowright, 1965b) . 
Serial passage by cell-associated techniques in calf kidney line cultures 
(BK/165) resulted in the liberation of measurable amounts of cell-free 
WCll virus by the forty-ninth passage. The cell-free virus could 
subsequently be passaged by cell-free technique in primary BTh cultures 
(Plowright, 1968). Early passages of the WCll cell-free virus 
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(103.8_105.8 TCID5o/ml) could be stored at 4C up to seven weeks without 
loss of viral infectivity (Plowright, 1967; Plowright, 1968) . The advent 
of cell-free WCll virus made development of serologic techniques for 
detection of antibody to wildebeest-derived MCF possible. 
Virus neutralization assay 
The first serologic technique developed was a constant virus tube 
neutralization (VN) assay (Plowright, 1967). Serum which inhibited viral 
cpe from developing in three or more tube cultures was considered 
positive. Antibody titers were expressed as the reciprocal of the serum 
dilution which protected 50% of the BTh cultures (log10SN50) . Plowright 
(1967) used the VN technique to survey East African blue wildebeest for 
the presence of neutralizing antibodies . Of 181 animals sampled, nine 
were negative , 26 had titers ranging from 100 . l to 100.8, 92 titers 100 .9 
to 101.8, and 54 had titers greater than 102 .0. The mean titer of animals 
three years or older was 101.7. Six of the VN negative wildebeest were 
less than four weeks of age and were also negative for rinderpest 
antibodies which seemed to indicate lack of colostral antibody transfer, 
as the dams were all WCll VN positive. Passive antibody titers in young 
wildebeest were generally equivalent to, or higher than their dam ' s 
antibody titer. The mean antibody titer was generally high (101.9) the 
first two months of life due to pass ively acquired antibodies, then 
declined from the second to fourth month of life to a low of 101.19, and 
then increased to a mean titer of 102.29 at 13 to 18 months of age. 
Plowright (1967) demonstrated that wildebeest did not pass through a 
seronegative phase between loss of passive antibodies and development of 
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active immunity. Eleven of 12 viremic wildebeest calves one to 20 weeks 
of age were VN positive . Failure of passive antibody transfer, and lack 
of adequate time for development of active immunity was used to explain 
the seronegative calf. All viremic wildebeest greater than six weeks of 
age were VN positive. Plowright (1967) concluded that passive antibodies 
did not interfere with AHV-1 infection or subsequent development of active 
immunity . The presence of neutralizing antibodies in viremic wildebeest 
whole blood didn't prevent transfer of infection to cattle. Immune 
tolerance could not be demonstrated (Plowright, 1967). Plowright (1967) 
hypothesized that the cell-associated nature of the AHV-1 virus might be 
responsible for both the lack of passive antibody interference and failure 
of immune tolerance to develop. The presence of virus induced surface 
antigens on lymphocytes expressing intracellular virus was suggested to 
explain the development of neutralizing antibodies to a cell-associated 
virus (Plowright, 1964). 
Plowright (1968) used the VN to follow development of MCF 
neutralizing antibodies in cattle. Neutralizing antibodies were rarely 
detected in animals during clinical disease. Low level neutralizing 
antibody (1:6) were first detected approximately eight weeks after the 
onset of viremia in cattle which survived (Plowright , 1968). Cattle which 
recovered were shown to be solidly immune to challenge with virulent AHV-1 
(Plowright, 1968) . Seropositive cattle challenged with virulent AHV-1 
virus demonstrated an anamnestic humoral response with development of high 
neutralizing antibody titers (1:60) (Plowright, 1968) . Cattle 
hyperimmunized with avirulent virus developed high neutralizing antibody 
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titers , but were susceptible to challenge with virulent AHV-1 (Plowright 
e t al . , 1975) . Neutralizing antibodies in cattle were primarily IgG1 
based on their half life of seven to nine days (Plowright et al., 1972) . 
Colostral antibodies were primarily IgG1 (Plowright et al., 1972) . 
Kalunda (1975) used the tube VN to follow development of neutralizing 
antibodies in 50 cattle experimentally infected with AHV-1 virus. He was 
unable to detect neutralizing antibodies in cattle with acute clinical 
disease . Thirteen cattle which had prolonged clinical disease or had 
recovered were seropositive with titers ranging from 1:8 to 1 : 128 . 
Kalunda used the WCll VN to investigate antigenic cross reactivity be tween 
AHV-1 and other herpesviruses. Antisera to infectious bovine 
rhinotracheitis virus , de rmopat hic herpesvirus, Marek's disease virus , 
duck plaque virus , and cytomegalov irus did not neutralize the WCll virus . 
Antisera to the WCll virus didn't significantly neutralize infectious 
bovine rhinotracheitis virus or de rmopathic bovine herpesvirus . Kalunda 
(1975) tested 36 sheep sera from an Australian flock with a high incidence 
of MCF in associated cattle (Dr . Snowden , Australia) , sera from 16 cattl e 
with sheep -goat-associated MCF and 22 contact cattle (Dr . Storz, Colora do ), 
and six bovine which had recovered from MCF-like disease (Kahrs, USA and 
Snowden , Australia). He found five sheep to be s e ropositive with tite rs 
of 1:4 to 1 : 16 , and three of the r ecovered cattle to be seropositive with 
titers of 1 :4 to 1 : 16 . 
A survey of East African game ani mals using the tube WCll VN was 
completed by Reid et al. (1975). Neutralizing antibodies were dete cte d i n 
sera f r om three species of the subfamily Alcelaphinae (topi, hartebeest, 
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and blue wildebeest), and one species of the subfamily Hippotraginae 
(fringe-eared oryx). In topi, passive neutralizing antibodies were 
detectable in calves up to two months of age. The majority of topi calves 
then passed through a seronegative phase before developing active immunity 
at around seven months of age. A seronegative phase was not detected in 
the hartebeest or wildebeest. Seropositive topi and hartebeest had titers 
of 0 . 095 log10SN50 or less. Antibody titers in two oryx were 100.S and 
101.4. The mean WCll VN titer for wildebeest was 101.93±0.11. This 
difference in antibody titer suggested that neutralizing antibodies 
detected in oryx, topi , and hartebeest were in response to infection with 
viruses antigenically related, but not identical to the AHV -1 virus (Reid 
et al ., 1975) . 
Adaptation of the VN technique to a microtiter plate system was 
achieved by Mushi and Plowright (1979). The microtiter VN was 
demonstrated to be highly reproducible with comparable sensitivity to the 
tube VN. Advantages of the microtiter system include d use of smaller 
quantities of reagents, elimination of dispensing the serum virus 
mixtures, and shorter assay time. The microtiter VN demonstrated a strong 
correlation between serum antibody titer and virus dose (correlation 
coefficient r - 0.96). A standard virus dose of 50 to 200 TCID50 was 
recommended (Mushi and Plowright, 1979). The microtiter VN was used to 
follow development of antibodies in rabbits and cattle experimentally 
infected with AHV-1 (Rossiter e t al . , 1977). They were unable to detect 
neutralizing antibodies in cattle. In rabbits, neutralizing antibodies 
were detected as early as one day before the onset of pyrexia, but not al l 
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of the rabbits developed neutralizing antibodies. A mean titer of 10°· 85 
was present on day three of clinical disease. The highest antibody titer 
detected in rabbits was 101.7 . In a second study, Rossiter (1982b) failed 
to detect neutralizing antibodies in five experimentally infected rabbits. 
Rurangirwa and Mushi (1984) demonstrated that hyperimmunized rabbits 
developed good neutralizing antibody titers. 
The addition of complement to the serum virus mixture prior to 
neutralization was investigated to determine if complement would enhance 
virus neutralization (Rossiter et al., 1977). Addition of guinea pig 
complement did not appear to enhance neutralization of the WCll virus 
regardless of disease stage when the serum was drawn. 
Sera from 13 Kenyan cattle with wildebeest-derived MCF were tested by 
the microtiter VN (Rossiter et al., 1980). Six of the cattle were 
seropositive and one was questionable. Serum from normal cattle were all 
negative. The VN technique was determined to have good specificity, but 
low sensitivity for detection of neutralizing antibodies in clinically 
affected cattle. 
Mushi and Karstad (1981) found neutralizing antibodies in 50 
fringe-eared oryx (Oryx gaze lla callotis) without wildebeest exposure. 
The mean titer in adults was 101 . 23. A seronegative phase between loss of 
passive antibody and development of active immunity (two to nine months of 
age) was observed in oryx calves . Natural transmission between oryx and 
cattle has not been documented. 
Rossiter (198la) used the VN to test sera from 167 sheep, many of 
which had been associated with MCF outbreaks, for neutralizing antibodies. 
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All were seronegative. Virus neutralization assays completed by Harkness 
(1985) on sheep, and cattle with sheep-goat-associated MCF in England 
found 86 of 508 sheep to be seropositive with titers from 1:2 to 1:32, and 
two of 15 cattle with confirmed cases of MCF to be seropositive. Harkness 
(1985) detected neutralizing antibodies in one of 21 clinically affected 
cattle, seven of 28 contact sheep, and one of 12 contact cattle from 
clinical MCF outbreaks in Shrewsbury and Northhampton. Rossiter (1983) 
used the VN to test sera from seven deer and 48 cattle with 
sheep-goat-associated MCF. All of the sera were negative. Heuschele and 
Castro (1984) also reported that clinically affected cattle, and domestic 
sheep and goats were rarely VN positive. Wan and Castro (1986) detected 
neutralizing antibodies in four of 98 cattle with natural and experimental 
cases of sheep-goat-associated MCF. All of these serologic findings lent 
support to Rossiter's hypothesis of antigenic relationship between the 
etiological agent of sheep-goat-associated form, and the AHV-1 virus 
group. A standardized microtiter WCll VN technique has been described 
(Heuschele et al., 1985c). 
Antigenic relationships, as detected by the serum virus 
neutralization assay, were not demonstrated between alcelaphine 
herpesvirus-1 and bovine herpesviruses (BHV) 1-3 (Heuschele, 1982; Hamblin 
and Hedger, 1984). 
Serologic surveys for the detection of neutralizing antibodies to MCF 
virus in exotic ruminants were completed by Heuschele et al . (1984a), 
Hamblin and Hedger (1984), and Barnard (1985). A high prevalence of 
neutralizing antibodies were demonstrated in whitetailed wildebeest, 
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whitebearded wildebeest, brindled wildebeest, topi, hartebeest, addax, 
scimitar-horned oryx, fringe-eared oryx, and gemsbok (Heuschele et al., 
1984a) . Species tested positive for neutralizing antibodies to 
alcelaphine herpesvirus-1 are presented in Appendix IV . 
Indirect i mmunofluorescence assay 
Indirect immunofluorescence assays (IFA) have been shown to be 
easier, faster, and more sensitive than VN assays for many herpesviruses. 
The IFA was adapted for use with the cell-free WCll virus using embryonic 
bovine kidney (BEK) cultures (Rossiter et al., 1977). Positive 
fluorescence patterns included both particulate and diffuse intranuclear 
and cytoplasmic fluorescence often with an intensely staining paranuclear 
body. Specificity of the fluorescence was demonstrated using blocking and 
absorption techniques. The IFA titer was the reciprocal of the highest 
dilution demonstrating specific fluorescence. Low level antigenic cross 
reactivity with other herpesviruses, especially BHV-1 and BHV-3, has been 
reported by several investigators (Appendix V). A single serotype for the 
AHV-1 group of viruses was proposed based on IFA serological findings 
(Rossiter et al., 1977). 
The IFA was used to follow antibody deve lopment in rabbits, and 
cattle experimentally infected with AHV-1 virus (Rossiter et al., 1977). 
Antibodies could be detected in cattle as early as six to seven days 
before the onset of pyrexia (IFA titer of 1 :8). Antibody titers continued 
to rise through the incubation period to a mean titer of 1:768 on the 
first day of clinical disease, and remained high t hrough the course of the 
disease (mean titer> 1:512). In rabbits, IFA antibodies were detected 
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four to six days post inoculation (IFA titer of 1:8). Antibody titers 
rose through the incubation period to a mean titer of 1:200 on day one of 
the clinical disease , and continued to rise t hrough the course of the 
disease (mean titer of 1:1024). Antibodies against the AHV-1 virus, in 
both cattle and rabbits, could be de tected earlier and with highe r titers 
by the IFA than by the VN (Rossiter et al., 1977). They hypo t hesized that 
antibodies detected by the IFA were no t directed against the same surface 
viral antigens as neutralizing antibodies, but were d i rected against viral 
antigens expressed earlier in the infectious process. 
Rossiter ( 198la) used the IFA technique to test sheep sera for 
antibodies directed against the AHV-1 virus. He found 162 of 167 sheep 
seropositive (mean titer 4.4 log2). including gnotobio t ic lambs which he 
took as evidence of congenital transmission of the etiological agent of 
s heep-goat-associated MCF. 
Rossiter (1983) used t he IFA technique to demonstrate antibodies to 
the AHV-1 v irus in 38 of 48 cattl e with histopathologically confirmed 
cases of sheep - goat -associated MCF. The pattern of IFA fluoresence was 
the same with positive sera from both forms of the disease . Rossiter 
(1983) f urther hypothesized that the etiological agen t of the 
s heep -goat -associated form i s antigenically related, but not identical to 
t h e AHV - 1 virus since few IFA positive sera from s heep or cattle with 
sheep-goat-associated MCF were VN positive. Ha rkness (1985) used IFA to 
examine sera from 21 cattle with clinical sheep-goat-associated MCF, SO 
normal cattle, and 51 cattl e presented for other clinical diseases. 
Sixty-two percent of the cattle with clinical MCF, six percent of the 
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normal cattle, and two percent of cattle presented for other diseases were 
IFA positive . Harkness ( 1985) then used the IFA on cattle and sheep sera 
from MCF clinical outbreaks in Shrewsbury and Northhampton. In the 
Shrewbury outbreak, three of four c linically affected cattle, none of the 
contact cattle, and three of 19 contact sheep were IFA positive. Whereas, 
two of 17 clinically affected cattle, and none of the contact sheep or 
cattle were IFA positive in the Northhampton outbreak. The low percentage 
of IFA positives in the Northhampton outbreak Harkness felt could be 
explained in one of three ways, either not all clinically affected animals 
were infected with MCF virus, a percentage of the infected animals fail to 
develop detectable levels of antibodies or sheep-goat-associated MCF has 
multiple etiological agents, some of which may not be antigenically 
related to the AHV-1 v irus group. Indirect immunofluorescence antibodies 
were also detected in cattle with clinical sheep-goat-associated MCF by 
Heuschele et al. (1984a). 
To study antibody development to early antigens of the AHV-1 virus , 
cytosine arabinoside (25 µg/ml), a DNA inhibitor, was used to prevent the 
production of WCll late antigens in BEK monolayers used for cover slip 
preparation (Rossiter et al., 1978). With this technique, termed IFA(E), 
two early WCll antigens, a diffuse whole cell antigen (DEA ) and a 
particulate intranuclear antigen (PEA) were identified. The DEA antigen 
was present in the cytoplasm of WCll infected BEK cells at 12 hours and in 
the nucleus at 24 hours post-inoculation. Whereas, the PEA antigen took 
24 to 36 hours to develop. Antibodies to the PEA antigen were detected in 
acute and hyperimmune cattle and rabbit antisera. Antibodies to the DEA 
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antigen was detected only in hyperimmune antisera. Rabbits produced few 
antibodies to early antigens during clinical disease. In cattle, 
antibodies to early antigens developed later and had lower titers (four to 
eight-fold) than antibodies directed against late antigens (IFA(L)). 
Adsorption and blocking techniques demonstrated the fluorescence to be 
specific. The IFA(E) assay was used to test sera from 13 Kenyan cattle 
with acute wildebeest-derived MCF (Rossiter et al., 1980). Positive 
fluorescence (PEA antigen) was detected in all 13 cattle with a mean titer 
of 1:26 (range 1:8 to 1:64). Fluorescence was rarely detected in sera 
from normal cattle. Rossiter (198la) used the IFA(E) technique to test 
antisera from 13 clinically normal sheep . All 13 sheep were IFA(E) 
positive with a mean titer of 1 : 22 as compared to the mean IFA(L) titer of 
1:90 for the same sheep . The pattern of IFA(E) fluorescence noted with 
the positive sheep sera was very similar to that seen with positive cattle 
or wildebeest sera (Rossiter, 198la). Rossiter (1983) used the IFA(E) 
assay to test sera from cattle with sheep-goat - associated MCF. Seven of 
the 12 cattle tested were positive with a mean titer of 1:32 as compared 
to a mean titer of 1:282 for the IFA(L) assay. Detection of antibodies to 
WCll early antigens in sheep and clinically affected cattle with 
sheep-goat-associated MCF supported Rossiter's hypothesis of antigenic 
relationship between the AHV-1 virus and the etiological agent of 
sheep-goat-associated form of MCF . 
Species of animals in which !FA antibodies against AHV-1 virus have 
been detected are presented in Appendix VI. 
33 
Plague reduction assay 
A plaque reduction assay using cell-free WCll virus was described by 
Russell (1979) . Plaque reduction titers were reported as the reciprocal 
of the last dilution of antiserum reducing plaques by 90%. Bovine testes 
cultures were highly variable in growth and virus sensitivity making 
reproducibility of this assay difficult. An enhanced plaque reduction 
phenomenon with the use of hypotonic media (SO-fold dilution with 
distilled water) was described by Russell (1979). Using this assay, he 
was able to demonstrate enhanced plaque reduction (six to 13-fold) of a 
single WCll hyperimmune bovine serum. The virus infectivity appeared 
unchanged. The increased titer was hypothesized to be due to enhanced 
antigen-antibody binding (Russell, 1979). 
A rabbit kidney cell line (RK13) was used in a separate plaque 
reduction assay described by Hazlett (1980). The plaque reduction titer 
was calculated by linear regression and represented the dilution r educing 
SO% of the virus control PFU (NDso). Hazlett (1980) used the assay to 
detect neutralizing antibodies in the sera of three blue wildebeest (1:120 
to 1:480) and nasal secretions of one wildebeest. He felt the RK13 line 
had a sensitivity comparable to prima r y thyroid cultures. 
Complement fixation assay 
Kalunda (197S) described a tube complement fixation assay (CF) for 
MCF based on the method of Casey. Serum dilutions inhibiting more than 
70% hemolysis were considered positive. Kalunda (197S) adapted the assay 
to a microtiter system. The assay was performed on serial serum samples 
from SO cattle experimentally infected with AHV-1. Antibody titers 
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ranging from 1:16 to 1:128 were detected in eight cattle (16%) which had 
recovered or had prolonged chronic cases of MCF. Complement fixing 
antibodies were never detected before virus neutralizing antibodies, and 
the CF titers were generally equivalent to , or lower than their respective 
VN titer. The CF assay could not detect viral antigens in tissues of 
infected cattle. 
A modified microtiter CF assay using normal bovine serum in the 
complement dilution was described by Rossiter et al. (1980). This assay 
detected significant levels of background antibodies (mean titer 1:8) in 
normal cattle. Anticomplementary activity of the bovine sera or cross 
reactivity with other bovine herpesviruses were suggested as two possible 
explanations for the high background (Rossiter et al., 1980). Thirteen 
cattle with wildebeest-derived MCF had a mean CF titer of 1:32 . Detection 
of tissue viral antigens was not possible with this assay. 
Hamdy et al. (1980) used two methods of complement fixation, serum 
dilution (Laboratory Branch CF Method, 1965) and complement dilution 
(modified Nakamura method, 1958), for detection of CF antibodies in 44 
cattle experimentally infected with AHV-1 virus. Seventeen of 44 (39%) 
were positive with titers ranging from 1 :8 to 1:256 by the serum dilution 
technique beginning at 28 days post-inoculation. Antibodies were detected 
in 32 of 44 (72%) cattle by the complement dilution assay beginning at 21 
days post-infection. The complement dilution technique could be used to 
test sera with anticomplementary activity. Cross reactivity with antisera 
against foot and mouth disease virus, rinderpest virus, bovine virus 
diarrhea virus, infectious bovine rhinotracheitis virus, Ibaraki v irus , 
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and bovine herpes mammillitis virus were not demonstrated. All CF 
positive sera were also VN positive (Kalunda and Dardiri unpublished, 
cited by Hamdy et al., 1980). 
Immunodiffusion assay 
Kalunda (1975) described an immunodiffusion assay (ID) to detect MCF 
precipitating antibodies. Using this technique with cattle experimentally 
infected with AHV-1 virus, he demonstrated precipitating antibodies only 
in animals which ha d recovered or had prolonged chronic cases. The ID 
assay was less sensitive than either the CF assay or the VN assay. 
An improved ID technique was described by Rossiter (1980b). This 
assay was used to detect AHV-1 precipitating antibodies in three of nine 
experimentally infected rabbits , zero of 14 experimentally infected 
cattle, 62 of 176 wildebeest, and three of 20 hartebeest. Precipitating 
antibodies were detected in one of 13 cattle with acute wildebeest-derived 
MCF. This was the first report of precipitating antibodies in cattle with 
clinical disease. Precipitating antibodies were not detected in the sera 
of 19 topi, 20 sheep, or 144 normal cattle. Antigenic cross reactivity 
between the positive ID antigen and hyperimmune sera against BHV-1 , BHV -2, 
rinderpest virus, and BVD virus were not detected. The ID assay was less 
sensitive than the VN, the CF, and the IFA assays. The ID assay had a 
relative sensitivity compared to IFA (positive threshold 1:32) of 10% for 
cattle sera , 36% for wildebeest sera and 38% for rabbit sera. Rossiter 
(1980b) used the ID assay to demonstrate antigenic relationship between 
the WCll (AHV-1) and K/30 (AHV-2) isolates. The ID assay failed to detect 
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viral antigens in tissues of cattle with acute MCF (Kalunda, 1975; 
Rossiter, 1980b). 
Indirect immunoperoxidase technique 
Rossiter (198lb) examined the indirect immunoperoxidase (IIP) 
technique for detection of MCF antibodies in experimentally AHV-1 infected 
cattle. Staining of particulate intranuclear early and late antigens, and 
particulate and diffuse cytoplasmic antigens by acute phase sera of cattle 
were observed. Nonspecific staining of rounded cells was also observed. 
The IIP titer was reported as the reciprocal of the highest serum dilution 
giving positive staining of nonrounded cells. A positive threshold of 
1:32 was selected. Antibody titers greater than 1:32 were not detected in 
the sera of normal cattle. Antibody titers greater than 1:32 were 
detected in 23 of 23 cattle with wildebeest-derived MCF (mean titer 
1:320). Rossiter (198lb) detected IIP antibodies in 14 cattle 
experimentally infected with AHV-1 one to two days prior to detection of 
IFA antibodies. In cattle, IIP titers were up to eight-fold higher than 
IFA titers during clinical disease. 
The IIP technique was used by Rossiter (1982b) to follow development 
of MCF antibody in experimentally AHV-1 infected rabbits. Rabbits 
developed both IgM and IgG IIP antibody as early as six days before the 
onset of pyrexia. All rabbits were IIP positive by two days before the 
onset of pyrexia (mean titer IgM 1:32, mean titer IgG 1:22). The mean IgM 
titer increased less than two-fold over the course of the clinical disease 
to a mean titer of 1:83. The IgG mean titer rose exponentially during 
clinical disease to a mean titer of 1:218. 
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Counterimmunoelectrophoresis assay 
A counterimmunoelectrophoresis (CIEP) assay for detection of MCF 
precipitating antibodies was described by Rossiter (1980b). MCF 
hyperimmune rabbit and cattle sera formed two to three precipitin lines 
against the positive (WCll) antigen. Precipitin lines against the 
negative (BEK) antigen were not detected with normal or hyperimmune rabbit 
sera, but were present in 54% of the normal bovine sera, and more than 33% 
of the alcelaphinae sera . Possible causes for the nonspecific reaction 
were not determined. Precipitating antibodies against the WCll antigen 
were detected in three of nine experimentally AHV-1 infected rabbits (all 
ID positive), 133 of 176 wildebeest, four of 19 topi, and two of 20 
hartebeest. The CIEP assay was two to four times more sensitive than the 
ID assay, but less sensitive than the IFA assay. The high levels of 
nonspecific reaction with bovine sera prevented the use of this assay to 
detect precipitating antibodies in cattle. Cross reactivity did not occur 
between the WCll antigen and hyperimmune sera produced against BHV-1, 
BHV-2, rinderpest virus, or BVD virus. The CIEP assay failed to detect 
viral antigens in infected tissue. 
Enzyme-linked immunosorbent assay 
Wan and Castro (1986) described a verification enzyme-linked 
immunosorbent (ELISA) assay using positive (greater kudu isolate, Castro 
et al., 1981) and negative (BEK) sonicated nuclear homogenate antigens. 
The nuclear extracted whole virus antigens were used because they were 
hypothesized to result in lower background absorbance values than 
semipurified cell-free whole virus antigen. The higher background absorban 
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absorbance with cell-free virus was suggested to be related to the 
incorporation of host cell proteins into the viral envelope during budding 
through cellular membranes . The mean absorbance for 88 seronegative 
cattle was 0 . 085 ± 0.067 . Mean absorbance of the positive reference 
antiserum was 1 . 125 ± 0.140. Positive threshold was set at 0 . 150. 
Antigenic cross reactivity was not demonstrated between the positive ELISA 
antigen and hyperimmune antisera produced in cattle to BHV-1, BHV-2, and 
BHV-3 . Serial dilutions of antisera from three WCll VN postive ruminants 
demonstrated decreasing linear absorbance values with increasing 
dilutions. A 1:20 serum dilution was selected to screen antisera . 
Antisera from 42 exotic ruminant species (216 sera) were tested by the 
ELISA using anti-bovine ELISA conjugate (Wan et al. , 1988). Levels of 
positive ELISA reaction were affected by the binding affinity of the 
anti-bovine ELISA conjugate to each exotic species IgG. Many of the ELISA 
positive sera were from clinically normal exotic ruminants (wildebeest, 
hartebeest, topi , oryx , addax , and exotic sheep and goats) . The ELISA 
assay detected antibodies to AHV-1 in nine exotic ruminants with clinical 
MCF . Virus was subsequently isolated from eight of these animals. The 
ELISA results were compared to VN results (VN results supplied by 
Heuschele, San Diego Zoo, and Metz , National Veterinary Services 
Laboratories) for sensitivity and specificity . The results were in 
agreement for 73 negative and 110 positive sera. Fourteen sera were 
positive by the ELISA, and negative by the VN . Nineteen sera were VN 
positive, and ELISA negative. The VN titers for positive sera ranged from 
1:4 to 1:516, and the ELISA absorbance values ranged from 0.284-1.534. 
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The assay had a significant correlation as calculated by linear regression 
(r- 0.564, P <0.001). The sensitivity of the ELISA compared to the VN was 
85.3%, and the specificity of the ELISA was 83.9%. 
Antisera from cattle with clinical cases of sheep-goat-associated 
MCF, both natural and experimental, were tested by the ELISA and the VN 
(Wan and Castro, 1986). Thirty of 128 sera from cattle associated with 
MCF outbreaks in Colorado and California were ELISA positive. 
Neutralizing antibodies to AHV-1 were not detected in any of these sera. 
Sera from six of 24 cattle with natural cases of MCF in Colorado were 
ELISA positive. Three of the six cattle were VN positive. Preinoculation 
and post-inoculation sera from 24 cattle used in experimental transmission 
studies were tested by the ELISA and VN. One of 24 preinoculation sera 
was ELISA positive. Examination of paired serologic results demonstrated 
three seroconversions by the ELISA, and one seroconversion by the VN 
assay . The finding of ELISA seropositive cattle with the 
sheep-goat-associated form of MCF lends support to Rossiter's hypothesis 
of antigenic relationship between AHV-1 and the etiological agent of the 
sheep-goat-associated form . Wan and Castro (1986) concluded that the 
ELISA was a rapid, specific serologic technique which could be used with 
both forms of the disease for diagnostic purposes, and for screening large 
numbers of domestic and exotic ruminants for the presence of antibodies 
against MCF virus. 
Western blot 
Reid and Buxton (1985) used AHV-1 antigen in a western blot 
technique . Several major bands were detected using antisera from positive 
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wildebeest. A portion of these bands also reacted with positive sheep 
antisera. This was further evidence for partial antigenic relationship 
between AHV-1 and the etiological agent of the sheep-goat-associated form 
of MCF . 
Disease Control 
An efficacious vaccine for the AHV-1 virus is not currently available 
(Russell, 1980 ; Rossiter , 1982a ; Plowright, 1986) . Current method of 
disease control is separation of susceptible species from potential 
reservoir hosts , which makes identification of potential reservoir hosts 
critical . Serologic techniques can readily be used to assist in this 
identification process. 
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MATERIALS AND METHODS 
Cell Cultures 
Vero-Maru (VM) cell cultures (green monkey kidney cells, Panama) were 
split 1:5 once per week using minimum essential medium (F-15) and 7.5% 
fetal bovine serum (FBS). These cultures were used for propagation of the 
Indian gaur AHV-1 isolate (Castro et al., 1981), production of complement 
fixation antigens, and as the indicator cell system in the AHV-1 VN 
assays. Bovine turbinate (BT) cell cultures (McClurkin, National Animal 
Disease Center (NADC), Aines, Iowa) were split 1:3 once per week using F-15 
medium and 10% FBS. These cultures were used for propagation of the WCll 
AHV-1 isolate (Plowright, 1965b), preparation of viral cover slips, 
production of complement fixation antigens, as the indicator cell system 
in the bovine and porcine herpesviruses VN assays, and for preparation of 
WCll and normal host cell (NHC) enzyme-linked immunosorbent antigens. 
Cell cultures were periodically tested for the presence of mycoplasma and 
bovine virus diarrhea virus (BVD) with negative results. 
Viruses 
Two AHV-1 isolates were used in this study. The WCll isolate, 
considered to be the prototypic virus of the AHV-1 group, was isolated by 
cocultivation of the leukocyte fraction from 10 milliliters (ml) of 
uncoagulated (EDTA) blood from a female blue wildebeest calf less than one 
week of age with primary bovine thyroid (BTh) cultures (Plowright, 1965b) , 
and characterized as a highly cell-associated herpesvirus. Serial passage 
of this isolate by cell-associated techniques in calf kidney (BK/165) line 
cultures resulted in the liberation of measurable amounts of cell-free 
virus by the forty-ninth passage (Plowright, 1967). The cell-free virus 
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was subsequently passaged in Bth cultures. Cell-free WCll virus was 
provided by the Director, East African Veterinary Research Organization, 
Kikuyu, Kenya, to the Foreign Animal Disease Diagnostic Laboratory 
(FADDL), Greenport, New York, where it was maintained by tissue culture 
passage in primary or secondary BTh cultures. The cell-free WCll virus 
was subsequently lyophilized after sixty passages in BTh cultures. The 
lyophilized cell-free strain of WCll virus was received by the Diagnostic 
Virology Laboratory, National Veterinary Services Laboratories (NVSL), 
Ames, Iowa, from FADDL. The lyophilized WCll virus was propagated in VM 
cultures. Five blind passages in VM cultures using cell-associated 
passage techniques where completed before viral cytopathic effects (cpe) 
were detected. The WCll virus grown in VM cultures had reverted to 
cell-associated virus . Serial passage of the virus in BT cultures with 
selection for cell-free virus by filtration of virus inoculum through a 
0.45µm millipore filter prior to inoculation of culture flasks, and 
incubation at 34C allowed for the development of cell-free viral stocks 
which could be harvested, and stored at -70C. 
The Indian gaur isolate (IG30359) was isolated in embryonic bovine 
kidney (BEK) cultures (Castro et al., 1981) from huffy coat cells 
collected from an Indian gaur with clinical disease suggestive of MCF at 
the Oklahoma City Zoo, Oklahoma City, Oklahoma. The isolate was 
characterized as a cell-associated herpesvirus of the AHV-1 group by 
indirect immunofluorescence using a WCll reference antiserum provided by 
FADDL (Ferris et al., 1979). The isolate also neutralized the reference 
WCll antiserum. Low passage virulent IG30359 virus was provided to NVSL 
by Dr. A. E. Castro, Oklahoma State University, Stillwater, Oklahoma. The 
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isolate was maintained for over three years by serial passage every seven 
to 10 days in VM cultures using cell-associated passage techniques. 
Serial passage of this isolate in VM cultures with selection for cell-free 
virus by filtration of virus inoculum through a 0.45µm millipore filter 
prior to inoculation of flask cultures, and incubation at 34C resulted in 
the liberation of cell-free virus stock which could be harvested, and 
stored at -70C. 
The bovine and porcine herpesviruses used in the antigenic 
relationship studies were propagated in BT cultures from reference NVSL 
viruses. They included bovine herpesvirus-1 (infectious bovine 
rhinotracheitis virus, Colorado strain), bovine herpesvirus-2 (bovine 
herpes mammillitis virus), bovine herpesvirus-3 (DN599 virus), and porcine 
herpesvirus-1 (pseudorabies virus, Shope strain). 
All viral stocks were titered, examined by electron microscopy, 
streaked on blood agar plates for detection of bacterial comtaminants, and 
passaged through three blind passages to detect the presence of BVD virus 
or other adventitious viruses. All viral stocks used in this study were 
free of adventitious agents. 
Antisera 
Control negative and positive WCll antisera were obtained from 
conventional calf 9471. Preinoculation serum was screened at a 1:20 
dilution by indirect immunofluorescence for the presence of antibodies 
against pseudorabies virus (PHV-1), infectious bovine rhinotracheitis 
virus (BHV-1), bovine herpes mammillitis virus (BHV-2), DN599 virus 
(BHV-3), WCll virus, IG30359 virus, and BVD virus with negative results. 
The calf was inoculated intravenously with 10 ml of cell-free WCll virus, 
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and bled daily for 21 days. On day 23, the calf was given a second 10 ml 
dose of cell-free WCll virus by the intravenous route . Serum was drawn on 
day 30, and the antibody titers determined by the IFA and VN assays. The 
calf was exsanguinated on day 34 post-inoculation . All sera were tested 
for the presence of antibodies against the WCll virus by the IFA , the VN , 
and the ELISA. A positive control serum against the WCll virus was also 
produced in a gnotobiotic calf (GC #16). Weekly serum samples were tested 
for antibodies against the WCll virus by the IFA, the VN, and the ELISA . 
Control positive (OSU715, OSU713) and negative (OSU696) sheep 
antisera were provided by Dr . S. K. Wan, Oklahoma State University, 
Stillwater, Oklahoma . The positive antisera were produced against the 
greater kudu AHV-1 isolate (Castro et al., 1981). 
Field sera from goats tested by the IFA and the VN and found to be 
negative (Windy, Lolli) and weakly positive (0717-55 , VN 1:4) were used as 
negative and positive control sera. 
Field sera from 63 different animal species submitted to NVSL for MCF 
serology (1982 to 1986), 20 sera from three exotic species (two Formosan 
sika deer, 16 wildebeest, and two scimitar-horned oryx) provided by Dr. W. 
P. Heuschele, San Diego Zoo, San Diego, California, and six sera from 
three exotic species (one Indian gaur , one cape hartebeest, and four 
wildebeest) provided by Dr. S. K. Wan were tested by the IFA, the VN, and 
the ELISA for the presence of antibodies against the WCll virus. 
Animal species were classified and grouped for data presentation 
according to the International Species Inventory System (1974), with the 
exception of the subfamily Hippotraginae which was separated into two 
subfamilies, the subfamily Alcelaphinae which included the Alcelaphus, 
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Connochaetes, and Damaliscus genera , and the subfamily Hippotraginae which 
included the Addax, Hippotragus , and Oryx genera. 
Complement Fixation Assay 
Antigen preparation 
Positive and negative complement fixation antigens were prepared for 
both viral isolates using a modification of the procedure described by 
Kalunda (1975). Bovine turbinate cultures were used for the WCll isolate, 
and VM cultures for the IG30359 isolate. Briefly, nearly confluent cell 
culture flasks (two days) were infected with cell-free virus and incubated 
at 34C until 90% of the cell monolayer showed viral cpe. Uninfected 
culture flasks were processed identically for production of negative CF 
antigens. The flasks were put through a single freeze-thaw cycle (-70C). 
Cell debris was removed by centrifugation at 2000 rpm for 15 minutes. The 
clarified viral supernatant fluid was concentrated 10-fold by dialysis 
against polyethylene glycol (Carbowaxa) . The concentrated viral and 
negative supernatant fluids were used as antigens in the complement 
fixation assay. 
aFisher Scientific, Fairlawn, New Jersey. 
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Complement fixation procedure 
The complement fixation assay was performed as previously described 
by Jenney et al. (1982). Veronal buffered (VBS) saline (pH 7.2 to 7.4) 
was used as diluent. Antisera were diluted 1:5 in VBS and heat 
inactivated at 56C for 30 minutes. Optimal antigen dilutions were 
determined by block titrations. A three percent suspension of washed 
sheep red blood cells (SRBC) was prepared and standardized to give 
replicate spectrophotometric absorbance readings between 0.33 and 0.35 at 
550nm. Rabbit hemolysin (0.09 ml) containing two units of activity for 
sensitization of SRBC was added to 100 ml of VBS, and mixed with 100 ml of 
standardized SRBC suspension. The mixture was incubated for 10 minutes in 
a 37C water bath to sensitize the SRBC. Optimal guinea pig complement 
dilution (1:31) containing 1 . 9 CH100 units was determined by complement 
titration . Complement fixation at 37C for three hours and overnight at 4C 
were tried. 
Determination of Identity between exotic species IgG and Bovine IgG 
Antisera from 59 exotic species were tested by the double 
diffusion technique of Ouchterlony to determine complete or partial 
identity between immunoglobulins from exotic species and bovine IgG. One 
percent Noble agara in borate buffer (Appendix VII) was prepared and 
poured into petri dishes and allowed to harden to a thickness of 2.8mm. 
Seven well patterns with a center well surrounded by six outside wells 
were cut using a template with cutters for wells S.3mm in diameter and 
aDifco Laboratories, Detroit, Michigan. 
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2.4mm apart. Undiluted IgG fraction of rabbit anti-bovine (RAB) IgG (H + 
L)-(Organon Teknika Corp., West Chester, PA, Cat. No.-0202-0082) was 
placed in the center well of each pattern. Purified bovine IgG (IgG1 and 
IgG2)-(0rganon Teknika Corp., West Chester, PA, Cat.No.-6002-0080) diluted 
1:40 with phosphate buffered saline (PBS, O. OlM, pH 7.2) was placed in 
three alternate outside wells of each pattern. Antisera from different 
species diluted 1:40 with PBS were placed into the remaining three outside 
wells of each pattern. The dilution of antisera and bovine IgG which gave 
the best definition of precipitin lines had been determined by titration 
against undiluted IgG fraction of RAB . The plates were incubated in a 22C 
incubator overnight. Patterns were read for precipitin lines of identity 
or nonidentity with bovine IgG. 
Antigenic Re l ationships Between AHV-1, BHV 1-3, and PHV-1 
Antisera used to examine antigenic relationships between AHV-1, BHV 
1-3, and PHV-1 as detected by the IFA , the VN, and the ELISA were 
primarily hyperimmune antisera produced in cattle, gnotobiotic calves, and 
pigs by the personnel of the Diagnostic Virology Laboratory, NVSL. Sera 
480830la, VS512a, and 480860la were negative control antisera. Serum 
3548102a was a hyperimmune antiserum produced against the IG30359 virus. 
Sera C5763a, 350820la, pig #l, pig #3, pig #4, and GC 33a were hyperimune 
antisera produced against the Colorado strain of infectious bovine 
rhinotracheitis virus. Bovine sera 32, 56B, and 61 were BHV-2 VN positive 
field sera submitted to NVSL for BHV-2 serology. Hyperimmune BHV-2 
aAntisera produced in cattle; GC - production of antiserum in a 
gnotobiotic calf. 
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antisera were 3518201a, and GC 36a. Sera 3528201a, and GC 35a were 
hyperimmune antisera produced against DN599 virus . The Shope strain of 
PHV-1 was used to produce porcine antisera 3389, 19289, A266, and R239. 
Positive DN599 antisera 8549a, 4la, 5la, and 52a were provided by Dr. Van 
der Maaten, NADC, Ames , Iowa. Positive MCF antisera WAP43 (Formosan sika 
deer), 831041 and 84037 (wildebeest) were provided by Dr. W.P. Heuschele, 
San Diego Zoo, San Diego , California. Positive antisera 30359 (Indian 
gaur) and 30282A (bovine) were provided by Dr . A. E. Castro, Oklahoma 
State University, Stillwater, Oklahoma. 
Indirect Immunofluorescence Assay 
Viral cover slip preparation 
Confluent BT cultures were trypsinized and resuspended in F-15 medium 
containing 10% FBS at a 1:3 ratio. Cell suspension was seeded into racks 
of sterile Leighton tubes (1.5 ml/tube) containing removable glass cover 
slips. The racks were incubated at 37C for three days. Tubes in 
different Leighton racks were inoculated with BHV -1, BHV-2, BHV-3 , or 
PHV-1. The infected cell monolayers were incubated at 37C until early 
viral cpe was detected. The glass cover slips were removed, rinsed twice 
in O.OlM PBS, fixed in acetone, air dried, and stored in glass vials at 
- 70C. Cover slips could be stored at -70C for over 12 months without loss 
of viral antigen reactivity. 
Cell -associated IG30359 virus was used for AHV-1 cover slip 
preparation during the initial phase of this study. Briefly, confluent 
aAntisera produced in cattle; GC - production of antiserum in a 
gnotobiotic calf . 
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four to seven day VM cultures were trypsinized and resuspended in F-15 
medium containing 10% FBS at a 1:3 ratio. Cell-associated IG30359 virus 
was added to the cell suspension at a 1:300 dilution . The infected cell 
suspension was seeded into racks of sterile Leighton tubes (1.5 ml/tube) 
containing removable glass cover slips . The Leighton racks were incubated 
at 37C until early viral cpe developed (two to four days) in the cell 
monolayers. Cover slips were processed and stored at -70C as previously 
described. The cell-associated nature of this virus made it difficult to 
achieve uniform infectivity of cover slips. False negatives were 
occasionally seen due to lack of viral antigen on some cover slips. 
With the development of cell-free WCll virus stocks, coverslips were 
prepared using BT cultures. Confluent seven day BT cultures were 
trypsinized and resuspended in F-15 medium containing 10% FBS at a 1:1 
ratio . Cell-free WCll virus was added to the cell suspension at a 1:1000 
dilution. The infected cell suspension was seeded into racks of sterile 
Leighton tubes (1.5 ml/ tube) with removable glass cover slips. The 
Leighton racks were incubated at 37C until small plaques of viral cpe were 
present (five days). Cover slips were fixe d and stored as previously 
described. 
Indirect immunofluorescence procedure 
Viral cover slips were removed from -70C and laid cell-side-up on IFA 
staining boards and warmed to room temperature. Test sera, and known 
reference positive and negative control sera were diluted 1:20 in cold PBS 
(O.OlM). Each cover slip was overlaid with a diluted test serum. The 
cover slips were incubated in a humidified 37C C02 incubator for 30 
minutes. Excess serum was removed using two PBS rinses. Cover slips were 
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again placed on staining boards cell-side-up and overlaid with the 
appropriate fluorescein isothiocyanate (FITC)-labeled anti-species 
conjugate (Reagent Section, Scientific Services Laboratory, NVSL). The 
cover slips were incubated for 30 minutes in a humidified 37C C02 
incubator. Excess conjugate was removed using two PBS rinses followed by 
a distilled water rinse. Coverslips were air dried and mounted in 50% 
glycerol, and read for the presence of specific viral immunofluorescence 
using a UV rnicroscopea. Sera tested positive at the 1 :20 dilution were 
retested at a 1:100 dilution . 
Virus Neutralization Assay 
Standardized rnicrotiter plate VN assays were performed with each 
AHV-1 isolate. Antisera were diluted 1:2 in F-15 medium and 
heat-inactivated at 56C for 30 minutes. Serial two-fold serum dilutions 
(1:2 to 1 :256) were made in duplicate rows of a 96 well microtitration 
plate with 0 . 025µ1 diluter loops. Cell-free virus (100-300 TCID50/well) 
was added to the test wells. The plates were covered and incubated at 37C 
in a humidified C02 chamber for one hour. Vero-Maru cell suspension (1:3) 
was added to each well (100µ1/well). Plates were covered with plastic 
lids and incubated at 37C in a humidified incubator with four percent C02 
for 10 days. Plates were r ead for viral cpe. The reciprocal of the 
highest serum dilution demonstrating 100% neutralization was considered 
the antiserum titer. Controls used included cell controls, positive and 
aLeitz, Wetzlar, Germany, (200W ultra -high -pressure mercury lamp HBO; 
BG 23, BG 12, BG 38 filters). 
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negative serum controls, test serum controls, and a virus back titration 
by half log10 dilutions to determine viral dose (TCID50/well). 
Enzyme-linked Immunosorbent Assay 
Antigen preparation 
Positive (WCll) and normal host cell (NHC) ELISA antigens were 
prepared using a modification of the procedure described by Snyder and 
Erickson (1981) for pseudorabies ELISA antigen production. 
Differentiation of negative and weak positive antisera was not possible 
with the first two lots of ELISA antigens. The antigen production 
procedure was modified, and third lots of WCll and NHC antigens were 
prepared. Briefly, for the WCll antigen, medium was decanted from 20 
confluent three day old BT flasks (150cm2), and the cell monolayers were 
rinsed with F-15 medium to remove residual FBS. Twenty-five milliliters 
of F-15 medium containing one percent MPstm Concentrate (lOOX)a was added 
to each flask. The flasks were inoculated with cell-free WCll virus (1 
ml/flask), and incubated at 34C. When the cell monolayers developed 100% 
viral cpe (14 days) they were aseptically scraped and decanted into 50 ml 
centrifuge tubes, and centrifuged at 3000 rpm for 30 minutes at 4C. The 
clarifed viral supernatant fluids were collected and pooled to yield a 
final volume of 550 ml. Cellular pellets were discarded. The clarified 
supernatant fluid was filtered through a 0.45µm millipore fi l ter to remove 
additional host cell debris. The filtrate was placed in sterile 
aK C Biological, Lenexa, Kansas. 
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polyallomer tubesa and centrifuged through a 8 ml 40% sucrose cushion 
(Appendix VII) at 25,000 rpm for one hour at 4C using a SW28 rotor. The 
supernatant fluid was decanted from each tube, and 0 . 5 ml of sterile PBS 
(O.OlM) added. The tubes were covered with Parafilmb, and placed at 4C 
overnight to resuspend the viral pellets. The virus suspensions were 
collected into a glass flask, and the tubes were rinsed three times with 
sterile PBS to harvest residual virus. The final volume of resuspended 
virus was 11 ml . Examination of the concentrated virus by electron 
microscopy revealed only herpesvirus enveloped virions and naked 
nucleocapsids. An equal volume of antigen solubilization buffer (Appendix 
VII) was added to the concentrated virus and the mixture was stirred 
continuously for 24 hours at 4C. The solubilized antigen was centrifuged 
at 38,000 rpm for 90 minutes at 4C using a type 40.2 small fixed angle 
rotor . The tubes contained clear supernatant fluid and a small pellet of 
cell and viral debris. The top 0 . 2 ml of each tube was discarded to 
remove any lipoproteins. The remaining fluid containing the solubilized 
viral proteins (22 ml) , was harvested and dispensed in 0.5 ml aliquots in 
sterile glass serum vials and stored at -70C. 
The NHC antigen was produced by an identical procedure, except the BT 
flasks were not infected with virus . The resulting solubilized NHC 
antigen (8 ml) was dispensed in 0.5 ml aliquots in sterile glass serum 
vials and stored at -70C. 
aBeckman Instruments , Inc. , Palo Alto, California. 
bArnerican Can Company, Greenwich , Connecticut. 
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Antigens were evaluated for specificity. Optimal working dilutions 
were determined by block titrations against four standard controls: serum 
diluent control, negative serum control, weak positive serum control, and 
a strong positive serum control. The optimal working dilution of the WCll 
antigen was determined to be 1:400. The NHC antigen was then titrated 
around the WCll optimal dilution. The dilution of NHC antigen (1:500) 
that produced mean absorbance values for the serum diluent and negative 
serum control closest to those of the WCll antigen was selected. 
Enzyme labeled antispecies conjugates 
Three ELISA conjugates were used in this study. Optimal working 
dilutions for each conjugate were determined by block titrations against 
the standard control sera . Peroxidase labeled affinity purified rabbit 
antibody to sheep IgG (H + L)-(Cat. No.-04-23 - 06) was purchased from 
Kirkegaard & Perry Laboratories, Inc., Gaithersburg, MD, and used at a 
1:400 dilution for testing sera from domestic and exotic ovine species. 
Peroxidase labeled rabbit anti-goat ELISA conjugate (176R28601) produced 
by the Reagent Section of the Scientific Services Laboratory, NVSL, was 
used at a 1:1000 working dilution for testing sera from domestic goats and 
African pygmy goats. Commercial IgG fraction rabbit anti-bovine IgG (H + 
L)-(Cat. No.- 0202-0082) which recognized both subclasses of bovine IgG 
(IgG1 and IgG2) was purchased from Organon Teknika Corp., West Chester, 
PA, and conjugated with horseradish peroxidase by the Reagent Section of 
Scientific Services Laboratory, NVSL. The conjugate was used at a 1:150 
dilution for exotic species and at a 1:200 dilution for members of the 
genera Bison and Bos. 
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Coating ELISA microplates 
For the screen ELISA, the WCll antigen was diluted 1:400 in coating 
buffer (Appendix VII) in a glass flask and kept chilled (4C) while being 
dispensed into 96 well Immulon I microplatesa with a high precision 
pipetting device (100µ1/well). The plates were covered with plastic lids, 
double sealed in plastic bags (three plates/bag), and incubated overnight 
at 37C on a variable rotatorb set at 60 rpm. The plates were then placed 
in a 4C cooler and stored at least overnight prior to use. In the 
verification ELISA, alternate vertical rows were filled with WCll and NHC 
antigen using the same methodology. 
Enzyme-linked immunosorbent procedure 
The ELISA was performed with modifications by the procedure described 
by Snyder and Erickson (1981) for the pseudorabies ELISA. Antigen coated 
microplates were removed from 4C storage and warmed to room temperature. 
Excess antigen was removed using three consecutive washes with ELISA wash 
solution (Appendix VII) and a automatic plate washera· Following 
aspiration of the final wash solution, the plates were inverted and tapped 
on absorbent material to remove residual wash solution. Test sera and 
control sera (not heat-inactivated) were diluted 1:20 in serum diluent 
(0.0lM PBS with 0.4% tween-20, and one percent ovalbuminc for the genera 
Bos, genera Bison, and domestic and exotic sheep or O.OlM PBS with 0.4% 
aoynatech Laboratories, Inc., Alexandria, Virginia. 
bAmerican Dade, Miami, Florida. 
corganon Teknika Corp., West Chester, Pennsylvania. 
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tween-20 for the remaining animal species). Each control serum and the 
serum diluent control (100µ1/well) was placed into four replicate wells of 
each plate in a standard configuration. Each diluted test serum 
(100µ1/well) was placed into two replicate wells. The plates were covered 
with plastic lids and incubated at 37C for 30 minutes on a variable 
rotator set at 60 rpm. Excess serum was removed using three wash cycles 
with a three minute soak period between the dispensing and aspiration of 
each wash cycle . Following final aspiration of wash solution, the plates 
were inverted, and lightly tapped to remove residual wash solution . The 
appropriate antispecies ELISA conjugate diluted to its working dilution in 
conjugate diluent (O.OlM PBS with 0.4% tween-20, and one percent 
ovalbumin) was dispensed into each well (50µ1/well) with a multichannel 
pipetting device used exclusively for conjugates . The plates were covered 
with plastic lids and incubated at 37C for 30 minutes on a variable 
rotator set at 60 rpm. Excess conjugate was removed using three washes 
with three minute soak cycles . Substrate (ABTS) solution (Appendix VII ) 
was dispensed into each well (100µ1/well) with a multichannel pipetting 
device used exclusively for substrate. Uncovered plates were incubated at 
room temperature on a variable rotator set at 60 rpm for the appropriate 
time dependent on the anti-species conjugate being used. Sixty minutes 
was used for the rabbit anti-bovine conjugate, 30 minutes screen and 15 
minutes verification for the rabbit anti-goat conjugate, and 20 minutes 
screen and 15 minutes verification for the rabbit anti-sheep conjugate. 
The Dynatech MR-580 ELISA reader was allowed to warm up at least 30 
minutes prior to calibration. The reader was set for a dual wavelength 
reading with a test wavelength of 405nm and a reference wavelength of 
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450nm. The reader was calibrated using the substrate solution shortly 
before the plates were read to eliminate the effect of substrate color. 
Color change was proportional to time, temperature, and reagent volumes 
which were all stringently controlled. The 50% positive threshold value 
was calculated for each plate as the midpoint value between the mean 
absorbance value of the negative serum control and mean absorbance value 
of the weak positive serum control. Sera tested and found to be greater 
than or within five percent of the 50% positive threshold were retested 
using the verification ELISA. The methodology for the verification ELISA 
was identical to that used with the screen ELISA except each test serum 
was placed into two vertical replicate wells for each antigen (WCll and 
NHC). The mean WCll antigen absorbance value was divided by the mean NHC 
antigen absorbance value to give a signal to noise (S/N) ratio for each 
serum. For a serum to be considered positive the mean absorbance value 
had to be above the 50% positive threshold and the S/N ratio had to be 
greater than or equal to 1 . 8. 
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Statistical Analysis 
The arithmetic mean, standard deviation , and coefficient of variation 
were calculated for each serum tested by the screen or verification ELISA. 
The sensitivity and specificity of each serologic assay as compared to the 
other assays were calculated as follows: 
Sensitivity 
- true positives (1st assay) - false positives (1st assay) x 100 
true positives (2nd assay) 
Specificity 
- true negatives (1st assay) - fal s e negatives (1st assay) x 100 
true negatives (2nd assay) 
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RESULTS 
Development of Antibodies against the WCll Virus in 
Experimentally Inoculated Calves 
Sera from daily bleeding of calf 9471 and weekly bleeding of 
gnotobiotic calf #16 were tested by the IFA, the VN, and the screen ELISA 
to follow antibody development to the WCll virus (Table 1) . Antibodies 
against the WCll virus were first detected in calf 9471 at day 11 
post-inoculation by all three assays. Antibody titers continued to rise 
until day 20. A second intravenous inoculation of cell-free WCll virus on 
day 23 produced a marked anamnestic response by day 30. The calf was 
exsanguinated on day 34. Control sera for the ELISA assay were selected 
from those obtained from the daily bleeding of calf 9471. Days 0, 1, and 
2 were used as negative serum controls . Days 14 , 15, 16, 17, and a pool 
of day 13 and day 15 (13/15) were used as weak positive controls, and day 
34 was used as the strong positive control. Gnotobiotic calf #16 was 
first detected as seropositive on day 14 post-inoculation by the IFA and 
VN assays. Seroconversion by the ELISA was first detected at day 28 post-
inoculation, and probably represented a marked anamnestic response to the 
second intravenous inoculation of cell -free WCll virus . 
Complement Fixation Assay 
Block titrations of the WCll, IG30359, and the two normal (BT and VM) 
complement fixation (CF) antigens against sera from calf 9471 and 
gnotobiotic calf #16 diluted 1:5 in VBS showed strong (4+) 
anticomplementary activity with all four undiluted CF antigens, and 
complete hemolysis with a ll four antigens at the 1:5 dilution. All test 
controls reacted appropriately. Antigens were used at the 1:5 dilution in 
Table 1. Comparison of antibody development by three serologic assays in calves inoculated 
intravenously with the WCll strain of alcelaphine herpesvirus-1 
Serologic Assays 8 
Serial 
bleedingsb IFA WCll Screen ELISA 
VN 1 2 3 4 Mean +L- SD CV(%} 
calf 9471 
Day oc <1:20 <1:4 0.063 0 .076 0.067 0 . 085 0 . 073 0.010 13. 5 
1 <1:20 <1:4 0.054 0 .077 0.066 0 . 016 24.8 
2 <1: 20 <1:4 0.069 0 .082 0.076 0 .009 12 .2 
3 <1:20 <1 : 4 0 .068 0 . 077 0 . 073 0 .006 8 . 8 
4 <1 : 20 <1:4 0 . 108 0 . 064 0.086 0 .031 36 .2 
5 <1 :20 <1 : 4 0.082 0 . 082 0.082 0 .000 0.0 
6 <1 : 20 <1 : 4 0 .089 0.091 0 . 090 0.001 1. 6 
7 <1 : 20 <1:4 0.077 0.065 0.071 0 .008 12.0 
8 <1:20 <1:4 0.071 0.077 0.074 0.004 5.7 
9 <1:20 <1:4 0 .081 0.093 0 . 087 0.008 9 . 8 
10 <1 : 20 <1:4 0 . 102 0 . 086 0 . 094 0 .011 12 .0 
11 1:20 1:4 0.107 0 . 115 0 . 111 + 0 . 006 5 . 1 
12 1:40 1:4 0 . 144 0.124 0 . 134 + 0 . 014 10 . 6 
13 1:80 1:8 0 . 143 0 . 159 0 . 151 + 0 . 011 7 .5 
14 1:160 1:8 0.173 0.164 0.169 + 0 . 006 3.8 
15 1 : 320 1:16 0.186 0 . 163 0.175 + 0 . 016 9.3 
16 1:320 1 :16 0.202 0 . 194 0.198 + 0.006 2.9 
17 1 :640 1 : 32 0.177 0.188 0.183 + 0.008 4 . 3 
18 1:640 1:32 0.201 0.191 0.196 + 0.007 3.6 
19 1:1280 1:32 0.218 0 . 218 0.218 + 0.000 0 .0 
20 1 :1280 1:32 0.230 0 .241 0. 236 + 0.008 3.3 
21 1 :1280 1 :32 0 . 275 0.2 73 0 .274 + 0 .001 0.5 
23c 1:1280 1 :64 0 . 290 0 .32 3 0.307 + 0 .023 7.6 
30 1 :10240 1:512 0.551 0.582 0.567 + 0.022 3.9 
34 1:5120 1 :512 0 . 672 0.445 0 . 590 0 . 758 0 . 616 + 0 . 133 21. 6 
13/15d ND ND 0.128 0.141 0.169 0 .146 0 . 146 + 0 .017 11. 7 
Oil ND ND 0 .012 0.010 0 . 013 0.008 0.011 0.002 20.6 
gnotobiotic calf 16 
Day oc <1 :20 <1 :4 0 .013 0.018 0 . 016 0.004 22.8 
7 <1:20 <1 :4 0.012 0 .017 0.015 0 . 004 24.4 
14 1:80 1 :4 0 . 026 0 . 038 0.032 0.008 26 . 5 
21c 1:640 1:8 0.053 0.061 0.057 0.006 9 . 9 
28 1 : 2560 1:32 0 . 226 0 . 189 0.208 + 0.026 12 . 6 
32 1:2560 1:32-64 0.212 0.212 0.212 + 0.000 0.0 
aIFA - indirect immunofluorescence assay (WCll antigen); WCll VN - virus neutralization 
assay (100 TCID50) ; Screen ELISA - screen enzyme-linked immunosorbent assay-3rd WCll antigen 
1 :400, RAB ELISA conjugate 920BPV8402 1:150 , ABTS substrate 60 minutes ; Mean - arithmetic 
mean ; SD - standard deviation; CV(%) - coefficienct of variation. 
bThirty milliliters of whole blood was drawn each serial bleeding. 
cindicates days the calves were inoculated intravenously with WCll strain AHV-1. 
dweak positive ELISA control serum. 
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two further CF assays using IFA positive field sera. The first assay used 
a three hour complement fixation period at 37C, and the second an 
overnight 4C complement fixation period. All of the sera tested were 
negative for complement fixing antibodies. Since it wasn't known if any 
of the sera tested actually contained complement fixing antibodies, it 
could not be determined if the CF antigens were functional. Review of the 
literature on use of the CF assay for detection of AHV-1 antibody revealed 
the CF assay to be less sensitive than either the VN or the IFA (Kalunda, 
1975; Hamdy et al., 1980). Further work to develop this assay was not 
done. 
Determination of Identity between Exotic Species IgG and Bovine IgG 
The double diffusion technique demonstrated precipitin lines of 
complete or partial identity between bovine IgG and the immunoglobulins of 
55 of the animal species tested (Table 2). All 55 species demonstrated 
one strong precipitin line of identity with bovine IgG, and at least one 
weak precipitin line of identity or partial identity with bovine IgG. 
Precipitin lines of nonidentity with bovine IgG were demonstrated with 
members of the family Equidae and family Camelidae. 
Based on these data, it was deemed acceptable to use rabbit 
anti-bovine conjugate to test the 55 species in both the IFA and the 
ELISA. 
Table 2. Determination of identity between immunoglobulins from exotic species and 
bovine lgGa by double diffusion using IgG fraction of rabbit anti-bovine IgGb 
Species which have good identity wi th Bovine IgG: 
Family Cervidae 
Reeves muntjac (Muntiacus reevesi) 
Elds deer (Cervus eldi thamin) 
Formosan sika deer (Cervus nippon taiwanus ) 
Brown elk (Cervus elaphus) 
Tule elk (Cervus elaphus nannodes) 
Barasingha (Cervus duvauceli) 
Axis deer (Cervus axis) 
Pere Davids deer (Elaphurus david ianus) 
Chinese water deer (Hydropotes inermis) 
White-tailed deer (Odocoileus virginianus) 
Reindeer (Rangifer tarandus) 
Family Giraffidae 
Giraffe (Giraffa camelopardalis) 
Okapi (Okapia johnstoni ) 
Family Antilocapridae 
Pronghorn (Antilocapra americana) 
Family Bovidae 
American bison (Bison b ison) 
European bisonj\.lisent (Bison bonasus) 
Indian gaur (Bos gaurus) 
Ankole (Bos taurus) 
Banteng (Bos javanicus) 
Scottish highland cattle (Bos taurus) 
Domestic cattle (Bos taurus) 
Yak (Bos mutus) 
Cape buffalo (Syncerus caffer caffer) 
Eland (Taurotragus oryx) 
Nyala (Tragelaphus angasi) 
Sitatunga (Tragelaphus s pekei) 
Family Bovidae continued 
Greater kudu (Tragelaphus strepsiceros) 
Black duiker (Cephalophus niger) 
Waterbuck (Kobus ellipsiprymnus) 
Nile lechwe (Kobus megaceros) 
Cape hartebeest (Alcelaphus buselaphus caama) 
Wildebeest (Connochaetes sp .) 
Hunters hartebeest (Damaliscus hunteri) 
Blesbok (Damal iscus dorcas phillipsi) 
Addax (Addax nasomaculatus) 
Sable antelope (Hippotragus niger) 
Scimitar-horned oryx (Oryx dammah) 
Beisa oryx (Oryx gazella beisa) 
Gemsbok (Oryx gazella gazella ) 
Fringe-eared oryx (Oryx gazella callotis) 
Arabian oryx (Oryx leucoryx) 
Blackbuck (Antilope cervicapra) 
Grants gazelle (Gazella granti) 
Thomsons gazelle (Gazella thomsoni) 
Persian gazelle (Gazella subgutterosa) 
Dama gazelle (Gazella dama) 
Spekes gazelle (Gazella spekei) 
Gerenuk (Litocranius walleri) 
Dik dik (Madogua sp.) 
Suni (Neotragus moschatus) 
Klipspringer (Oreotragus oreotragus) 
Markhor (Capra falconeri) 
Nubian ibex (Capra ibex nubiana) 
Chamois (Rupicapra rupicapra) 
Saiga antelope (Saiga tatarica) 
Species which do not have good identity with Bovine IgG: 
Family Equidae 
Zebra (Eguus s p .) 
Family Camelidae 
Camel (Camel us sp.) 
Llama (Lama glama glama) 
Al paca (Lama glama pacos) 
aBovine I gG (Cat. No. 6002-0080), Organon Teknika Corp., West Chester , PA. 
brgG fraction-RAB IgG (H + L)-(Cat. No. 0202 - 0082) , Organon Teknika Corp., West Chester, PA. 
This product recognized both subclasses of bovine IgG (IgGl and IgG2). 
°' w 
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Antigenic Relationships Between AHV-1, BHV 1-3, and PHV-1 
Antigenic relationships detected by the indirect immunofluorescence assay 
All antisera were diluted 1:20 in cold PBS (O.OlM) and screened 
against each of the six viral antigens (Table 3). Sera determined to be 
IFA positive against any of the six viral antigens at the 1:20 dilution 
were titrated to determine the endpoint titer. Positive AHV-1 antisera 
did not demonstrate antigenic cross reactivity with any of the other viral 
antigens. Antigenic cross reactivity between BHV-1 antisera of bovine 
origin and the PHV-1 viral antigens were seen at endpoint dilutions 16 to 
64-fold lower than their respective homologous BHV-1 endpoint titers. 
Antigenic cross reactivity between BHV-1 antisera of porcine origin and 
the PHV-1 viral antigens were not demonstrated . Antigenic cross 
reactivity between BHV-2 antisera and other viral antigens were not 
demonstrated. Positive BHV-3 antisera demonstrated antigenic cross 
reactivity with both the WCll and the IG30359 viral antigens up to a 
dilution of 1:100. Calf 51 was seropositive for BHV-1 prior to 
inoculation with DN599 virus . Antigenic cross reactivity between PHV-1 
antisera and the other viral antigens were not demonstrated. 
Antigenic relationships detected by the virus neutralization assay 
The same antisera were tested by standard virus neutralization assays 
for each of the six viral antigens to detect antigenic relationships 
between the AHV-1 group of viruses and other herpesvirus. Homologous 
virus neutralizing antibody titers were determined for each antiserum. 
Antisera against the BHV-3 virus did not demonstrate positive homologous 
neutralizing antibody titers. Antigenic cross reactivity between the six 
Table 3 . Antigenic relationships among alcelaphine 
(AHV-1 ) he rpesvirus-1, bovine (BHV 1-3) , 
and porcine ( PHV- 1) herpesviruses as det ec ted 
by the indirect immunofluorescence ass ay 
Virus Infected Cover Slips a' b 
AHV - 1 BHV-1 BHV-2 BHV-3 PHV-1 
Antiserac WCll r r. 30359 IBR BHM DN599 PRV 
AHV-1 
3548102 5120 5120 <20 <20 <20 <20 
30359 320 640 <20 <20 <20 <20 
30282A 160 320 <20 <20 <20 <20 
WAP 43 5120 10240 <20 <20 <20 <20 
831041 320 320 <20 <20 <20 <20 
84037 1280 1280 <20 <20 <20 <20 
BHV-1 
C5763 <20 <20 10240 <20 <20 160 
3508201 <20 <20 5120 <20 <20 320 
Pig #l <20 <20 2560 <20 <20 <20 
Pig #3 <20 <20 5120 <20 <20 <20 
Pig #4 <20 <20 10240 <20 <20 <20 
cca33 <20 <20 5120 <20 <20 160 
BHV-2 
3518201 <20 <20 <20 20480 <20 <20 
32 <20 <20 <20 1280 <20 <20 
56B <20 <20 <20 2560 <20 <20 
61 <20 <20 <20 640 <20 <20 
GC36 <20 <20 <20 5120 <20 <20 
BHV-3 
3528201 <20 <20 <20 <20 20480 <20 
8549 100 100 <20 <20 5120 <20 
41 <20 20 <20 <20 2560 <20 
51 <20 <20 160 <20 320 <20 
52 <20 <20 <20 <20 1280 <20 
GC35 100 100 <20 <20 5120 <20 
PHV-1 
3389 <20 <20 <20 <20 <20 2560 
B302 <20 <20 <20 <20 <20 1280 
19289 <20 <20 <20 <20 <20 5120 
A266 <20 <20 <20 <20 <20 2560 
R239 <20 <20 <20 <20 <20 2560 
Controls 
4808301 <20 <20 <20 <20 <20 <20 
VS512 <20 <20 <20 <20 <20 <20 
4808601 <20 <20 <20 <20 <20 <20 
aWCll - blue wildebeest AHV-1 isolate ( Plowright 1965b) ; 
IG30359 - Indian gaur AHV - 1 (Castro et al., 1981); 
BHV-1 (IBR) - infectious bovine rhinotrache i t i s; BHV- 2 (BHM) = 
bovine herpes mamrnillitis; BHV- 3 (DN599) = movar bov ine 
herpesvirus; PHV-1 ( PRV) = pseudorabies ; GC = gnotobiot ic calf. 
bvirus infected cover slips were prepared using bovine 
turbinate monolayers. 
cAntisera were diluted 1 :20 in cold phosphate buffered 




herpes viruses was not demonstrated using virus neutralization assays 
(Table 4). 
Antigenic relationships detected by the enzyme-linked immunosorbent assay 
Bovine origin BHV 1-3 antisera, and normal bovine antisera were 
tested by the screen WCll ELISA. Antigenic cross reactivity between the 
WCll antigen and BHV 1-3 antisera were not demonstrated (Table 5). 
Indirect Immunofluorescence Assay 
Sera from 63 different animal species were tested by the indirect 
immunofluorescence assay for antibodies against alcelaphine herpesvirus-1. 
Of the 1089 animals tested, 236 (21.7%) were found to be !FA positive at 
the 1:20 serum dilution. Twenty-six different species were represented 
among the positive animals. The 236 !FA positive animals were retested at 
the 1:100 serum dilution. Of the 236 animls retested, 178 (75.4%) were 
!FA positive at the 1:100 dilution. Twenty-two species were represented. 
Positive animals included both AHV-1 infected animals as confirmed by 
virus isolation, and histopathologically confirmed cases of sheep-goat-
associated MCF. A summary of the !FA data at both the 1:20 and 1:100 
dilutions is presented by family and subfamily in Table 6, and by species 
in Table 7. 
Virus Neutralization Assay 
The same 1089 animals were tested by standard virus neutralization 
(VN) assays with both AHV-1 viral isolates. Neutralizing antibodies 
against the WCll virus were detected in 116 animals (10.7%) representing 
15 different species with VN titers ranging from 1:4 to 1:512. Sixteen 
different species, and 119 animals (10.9%) were IG30359 VN positive with 
Table 4. Antigenic relationships among alcelaphine 
(AHV-1) herpesvirus-1, bovine (BHV 1-3), 
and porcine (PHV-1) herpesviruses as detected 
by the virus neutralization assay 
Virus Neutralization Ti tersa,b 
AHV-1 BHV-1 BHV-2 BHV-3 PHV-1 
Antiser9c WCll IG30359 IBR BHM DN599 PRV 
AHV-1 
3548102 128 128 <4 <4 <4 <4 
30359 <4 <4 <4 <4 <4 <4 
30282A <4 4 <4 NTISd <4 <4 
WAP 43 512 512 <4 <4 <4 <4 
831041 32 32 <4 <4 <4 <4 
84037 128 128 <4 <4 <4 <4 
BHV-1 
C5763 <4 <4 256 <4 <4 <4 
3508201 <4 <4 256 <4 <4 <4 
Pig #l <4 <4 64 <4 <4 <4 
Pig #3 <4 <4 256 <4 <4 <4 
Pig #4 <4 <4 128 <4 <4 <4 
cca33 <4 <4 32 <4 <4 <4 
BHV-2 
3518201 <4 <4 <4 256 <4 <4 
32 <4 <4 <4 16 <4 <4 
56B <4 <4 <4 16 <4 <4 
61 <4 <4 <4 8 <4 <4 
GC36 <4 <4 <4 4 <4 <4 
BHV-3 
3528201 <4 <4 <4 <4 <4 <4 
8549 <4 <4 <4 <4 <4 <4 
41 <4 <4 <4 NTIS <4 <4 
51 <4 <4 4 NTIS <4 <4 
52 <4 <4 <4 NTIS <4 <4 
GC35 <4 <4 <4 <4 <4 <4 
PHV-1 
3389 <4 <4 <4 <4 <4 64 
8302 <4 <4 <4 <4 <4 64 
19289 <4 <4 <4 <4 <4 128 
A266 <4 <4 <4 <4 <4 64 
R239 <4 <4 <4 <4 <4 64 
Controls 
4808301 <4 <4 <4 <4 <4 <4 
VS512 <4 <4 <4 <4 <4 <4 
4808601 <4 <4 <4 <4 <4 <4 
aWCll - blue wildebeest AHV-1 isolate (Plowright 1965b); 
IG30359 - Indian gaur AHV-1 (Castro et al., 1981); 
BHV-1 (IBR) - infec t ious bovine rhinotracheitis; BHV-2 (BHM) = 
bovine herpes marnmillitis; BHV-3 (DN599) = movar bovine 
herpesvirus; PHV-1 (PRV) - pseudoraoies; GC = gnotobiotic calf. 
bstandard microtiter plate virus neutralization assays 
were performed for each virus. 
cAntisera were heat inactivated at 56C for 30 minutes. 
dNTIS = no test insufficient serum. 
°' '° 
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Table 5. Antigenic relationships between the WCll ELISA antigen 
and bovine herpesv iruses (BHV 1-3) as detected by the 
enzyme-linked immunosorbent assay 
WCll Enzyme-Linked Immunosorbent Assaya , b 
Ant i serac,d 1 2 Mean PTHb +/ - SDb CV( %)b 
BHV-1 
C5763 0.059 0.064 0.062 0.107 0 . 004 5 .7 
3508201 0.032 0.035 0.034 0 .098 0 . 002 6.3 
Gcd33 0.008 0.006 0.007 0.098 0.001 20.2 
BHV- 2 
3518201 0.020 0.017 0.019 0.098 0.002 11 .5 
32 0.035 0 . 032 0 . 034 0 . 114 0.002 6 . 3 
56B 0.055 0.064 0.060 0.098 0 . 006 10. 7 
61 0.045 0 . 049 0.047 0 . 107 0 . 003 6.0 
GC36 0.005 0 . 006 0.006 0 . 098 0.001 12.9 
BHV -3 
3528201 0 . 042 0 . 044 0.043 0 . 107 0 . 001 3. 3 
8549 0 . 058 0 . 055 0 . 057 0 . 098 0.002 3. 8 
41 0 . 036 0.036 0 . 036 0 . 107 0 . 000 0 . 0 
51 0 . 018 0.019 0.019 0 . 098 0.001 3 . 8 
52 0.027 0 . 026 0.027 0.098 0.001 2. 7 
GC35 0 . 009 0 . 009 0 . 009 0.098 0.000 0 . 0 
Controls 
4808301 0.032 0 . 034 0.033 0 . 098 0.001 4. 3 
VS512 0.026 0 . 025 0 . 026 0 . 098 0.001 2 . 8 
4808601 0.005 0 . 004 0.005 0.099 0 . 001 15. 7 
awcll ELISA-3rd WCll antigen 1:400, RAB ELA conjugate 920BPV8402 
1:200, ABTS substrate 60 minutes; WCll - blue wildebeest AHV-1 isolate 
( Plowright 1965b) . 
bPTH - 50% positive threshold ; SD - standard deviation; 
CV(%) - coefficient of variation. 
cAntisera were diluted 1:20 in PBS (0.0lM) with 0.4% tween-20, 
and one percent ovalbumin . 
dBHV-1 - infectious bovine rhinotracheitis; BHV-2 - bovine he rpes 
mammillitis; BHV-3 - movar group of bovine herpesvirus; 
GC - gnotobiotic calf. 
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VN titers ranging from 1:4 to 1:512. A Summary of the VN data for both 
AHV-1 isolates is presented by family and subfamily in Table 6, and by 
species in Table 7. 
Enzyme-Linked Immunosorbent Assay 
The same 1089 animals were tested by the screen ELISA. Two hundred 
and thirty-two animals (21.3%) representing 27 species were positive for 
antibodies against the WCll antigen. The positive sera were retested 
using the WCll verification ELISA. Two hundred and eighteen of the 232 
animals (94%) representing 25 species were verified as ELISA positive . 
ELISA positive sera were from animals with wildebeest-derived MCF , animals 
with histopathologically confirmed clinical cases of sheep-goat -associated 
MCF, and from reservoir host species. A summary of the data by family and 
subfamily is presented in Table 6, and by species in Table 7. 
Direct Comparison of the Serologic Assays 
Direct comparison of the serologic assays was completed using the 
1089 animals representing 63 different species from which serum had been 
tested for the presence of antibodies against the WCll virus by all three 
assays (Table 8). Eight hundred and three animals (73.7%) representing 33 
different species were seronegative by all three assays. One hundred and 
fourteen animals (10.5%) representing 15 different species were 
seropositive by all three assays. The serological results differed assay 
to assay for the remaining 172 animals (15.8%). Serological results of 
the 172 animals were as follows: 50 IFA negative, 122 IFA positive , 136 
VN negative, two VN positive, 34 VN no test, 68 ELISA negative, and 104 
ELISA positive. Pairs of serologic assays were compared for sensitivity 
and specificity. Comparison of the indirect immunofluorescence assay and 
Table 6. Serological data summarized by family and subfamily 




Mean i SDb 
(range) 
Family Camelidae 




Mean i SD 
(r ange ) 
subfamily Cervinae 
Me an i SD 







subfamily Odocoileinae 101 
Mean i SO 
(range) 
Family Giraffidae 
Mean i SD 
(range) 
Family Antilocapridae 




Mean i SO 
(range) 
subfamily Reduncinae 





subfamily Alcelaphinae 138 
Mean i SO 
(range) 
subfamily Bippotraginae 97 
Mean i SO 
( range) 
subfamily Antilopinae 
Mean i SO 
(range) 
subfamily Caprinae 



























































50.0 i 54.2 
(4-256) 
16 






























45 .9 i 57.0 






18.2 i 41.2 
(range) (4-128) ( 4-128) 
aIFA - indirect immunofluorescence assay; VN - virus 
neutralization assay; ELISA - enzyme-linked immunosorbent assay. 
bMean ± SD - mean VN titer or absorbance value ± one standard 
deviation ; ND - not done; NTIS - no test insufficient serum. 
Screen ELISA 
number neg 
WCll anti g en 
7 
0.043 i 0.020 
(0.026-0.086) 
10 
0.021 i 0.011 
(0.007-0.037) 
17 
0 . 061 i 0.011 
(0.037 - 0.084) 
19 
0.064 i 0 .018 
(0.032-0.097) 
96 
0.057 i 0.019 
(0.015 - 0.106) 
3 
0.034 i 0.007 
(0.029-0.042) 
1 
0.059 i 0 .0 
351 
0 .0 57 i 0.018 
(0.01 4- 0.098) 
8 
0.053 i 0.014 




0.510 i 0.253 
(0 . 170-1.072) 
5 
0.305 i 0.215 
(0.165-0 .676) 
42 
0 . 236 i 0.124 
(0.105-0.61 8 ) 
91 
0.04 5 i 0 .021 0.391 i 0.161 
(0.008-0.111) (0.161-0.995) 
77 
0.048 i 0 . 015 
(0.017-0.089) 
48 
0.047 i 0 . 015 
(0.011-0 .083) 
20 
0.304 i 0.132 
(0. 136-0.592 ) 
2 
0.167 i 0.031 
(0.1 45-0.189) 
173 68 
0.066 i 0.039 0.256 i 0.092 
(0.013-0.170) (0.119-0.516 ) 
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Verification Enzyme-Linked Immunosorbent Assay 
number neg 
WCll antigen NRC antigen 
14 
0.17 4 i 0.066 0.160 i 0 . 065 
(0.108-0.378) (0.097-0 .3 65) 
number pos 
WCll antigen NRC antigen 
4 
0.455 i 0.215 0.026 i 0.007 
(0. 156-0 .777) (0 . 018-0.034) 
5 
0.286 i 0 . 194 0.047 i 0.030 
(0.146 -0 . 608) (0.026-0.097) 
0.248 i 0.104 
(0 .113-0. 450) 
28 
91 
0.055 i 0.025 
(0.031-0.138) 
0.385 i 0.167 0.045 i 0.029 
(0.165-0.932 (0.002-0.150) 
20 
0.302 i 0.126 
(0.117-0.531) 
0.171 i 0.058 
(0.130-0 . 212) 
0.043 i 0.023 
(0. 019-0 .104) 
2 
68 
0.020 i 0.005 
(0.016- 0.023) 
0.273 i 0 .095 0.045 i 0.022 
(0.127-0.515) (0.011-0.109) 
Table 7. Serological data summarized by species 
Family 
sub:Camily 
s pe cies 
Family Equida e 
Zeb ra 
Mean ± SDb 
( range ) 
Family Camel idae 
Camel 
Mean ± SD 
( range ) 
Llama 
Mean ± SD 
( range) 
Alpaca 
Mean ± SD 
(range ) 
Family Cervi dae 
sub:Camily Muntiacinae 
Reeves muntjac 




Mean ± SD 
( range ) 
Formosan a i ka deer 
Mean ± SD 
( range ) 
Brown elk 
Mean ± SD 
(range ) 
Tu la elk 
Mean ± SD 
( range ) 
Barasingha 
Mean ± SD 
( range) 
Axis deer 
Mean ± SD 
(range ) 
Pere David s deer 
































































162 ± 223 .4 



























162 ± 223 . 4 










aIFA - indirect immunofluorescence assay; VN - virus 
neutralization assay; ELISA - enzyme-linked immunosorbent assay. 
bMean ± SD - mean VN titer or absorbance value ± one standard 




0 . 043 :t 0.020 
(0.026-0.086) 
7 
0 . 020 :t 0 . 011 
(0.007 -0 .037) 
1 
0 . 009 :t 0.0 
2 
0.030 :!. 0.002 
(0.028-0.031) 
17 
0 . 061 :t 0.0ll 
(0.037-0.084) 
1 
0 . 062 :!. 0.0 
3 
0.064 :t 0.0 14 
(0. 048-0. 074) 
l 
0.097 :t 0.0 
l 
0.072 :t 0 . 0 
7 
0.060 :t 0.019 




0.553 :!. 0.0 
2 
0 .477 :t 0.433 
(0. 170-1 . 072 ) 
2 l 
0 . 081 :t 0 .00 8 0.534 :t 0.0 
(0.075-0.087) 
4 
0.052 :t 0 . 019 
(0.032-0.078) 
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Ver i fication Enzyme-Linked Immunosorbent Assay 
number neg 
WCll antigen NHC antigen 
number pos 
WCll antigen NHC antig 
l 
0. 441 :!. 0.0 0.022 :!. 0 
2 
0.390 :t 0 .330 0.025 :t 0 
(0.156-0.777) (0.0 18-0. 
l 
0 . 598 :t 0 .0 0 .0 34 :t 
Table 7. (continued) 
Serologic Assays 
IFA IFA IG30359 WCll 
Family Numbe r 1 : 20 1:100 VN VN 
subfamily of number number n umber number 
species animals pos p os pos p os 
subfamily Odocoileinae 
Chinese water d eer 2 0 0 0 
Mean !. SOb < 4 <4 
( range ) 
White-tailed deer 92 3 3 0 0 
Mean :!:. SO < 4 <4 
(range ) 
Reindeer 7 0 NOb 0 0 
Mean :!:. SO <4 <4 
( range ) 
Family Giraffidae 
Giraffe 2 0 NO 0 0 
Mean :!:. SO <4 <4 
(r ange ) 
Okapi 0 HO 0 0 
Mean :!:. SO <4 <4 
(r ange ) 
Fami ly Antilocapridae 
Pronghorn 1 1 0 0 0 




Ameri c an bison 12 1 0 0 0 
Mean :!:. SO <4 <4 
( range ) 
European bison / Wisent 5 0 HO 0 0 
Mean :!:. so <4 <4 
( range ) 
Indian gaur 14 3 1 0 
Mean :!:. SO 4 <4 
( range ) 
Ankole 4 0 HO 0 0 
Mean :!:. SO <4 < 4 
( range ) 
Ban tang 11 0 NO 0 0 
Mean !. so <4 <4 
(range) 
Scottish highland 2 1 0 0 
Me an :!:. so <4 <4 
(range) 
Yak 2 0 HO 0 0 
Mean :!:. SO <4 <4 
( range ) 
Screen ELISA 
number neg 
WCll anti g en 
2 
0.051 ±. 0.043 
(0.020-0.081) 
87 
0.058 ±. 0.019 
(0.015-0.106) 
7 
0.048 ±. 0.014 
(0.025-0.071) 
2 
0.031 ±. 0.002 
(0.029-0.032) 
l 
0.042 ±. 0.0 
1 
0.059 ±. 0 .0 
10 
0.062 ±. 0.013 
(0.032-0.086) 
5 
0.037 ±. 0.011 
(0.019-0.048) 
12 
0 . 034 ±. 0.007 
(0.020-0.052) 
3 
0.038 ±. 0.013 
(0.024-0.050) 
11 
0.043 ±. 0.015 
(0.025-0.074) 
l 
0 . 031 ±. 0.0 
2 
0 . 047 ±. 0.006 
(0.039-0.062 ) 
number pos 
WCll anti g en 
5 
0.305 ±. 0.215 
(0.165-0.676) 
2 
0.121 ±. 0.023 
(0 . 015 - 0 .137) 
2 
0.166 ±. 0.031 
(0.144-0. 189 ) 
1 
0.157 ±. 0.0 
l 
0.176 ±. 0.0 
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Verification Enzyme-Linked Immunosorbent Assay 
number neg 
WCll anti g en NRC anti g en 
1 
0 . 179 ±. 0.0 0.188 ±. 0.0 
l 
0.191 ±. 0.0 0 . 167 ±. 0.0 
number pos 
WCll antigen 
0.286 ±. 0.194 
(0.146-0.608) 
0. 114 ±. 0.0 
0.200 ±. 0.035 
(0 . 175-0.25 4) 
0.205 ±. 0 .0 





0.047 ±. 0 
(0.026-0. 
0 .055 ±. 0 
0.037 ±. 0 
(0 .029-0 . 
0 .072 ±. 0 
Table 7. (continued) 
Sero logic Assays 
IFA IFA IG30359 WCll 
Family Number 1:20 1 : 100 VN VN 
subfamily of number number number number 
species animals pos pos pos pos 
subfamily Bovinae 
Domestic cattle 251 26 20 5 6 
Mean :!:. so 9 . 6 :!:. 12.5 6 .7 :!:. 4 . 8 
(r ange ) (4-32) ( 4 - 16) 
Cape buffalo 15 0 ND 0 0 
Mean :!:. SD <4 <4 
( range ) 
Eland 30 0 ND 0 0 
Mean :!:. SD <4 <4 
(rang e ) 
Ny ala 15 0 NO 0 0 
Mean :!:. SD <4 <4 
(range) 
Sitatunga 21 0 ND 0 0 
Mean :!:. SD <4 <4 
(range) 
Graeter ltudu 11 0 ND 0 0 
Mean :!:. SD <4 <4 
(range ) 
subfamily Reducinae 
Waterbuclt 0 ND 0 0 
Mean :!:. SD <4 < 4 
(range) 
Nile lechwe 1 0 ND 0 0 
Mean :!:. SD <4 <4 
(range) 
subfamily Alcelaphinae 
Bartebeest 26 23 20 18 18 
Mean :!:. SD 18 :!:. 16 . 4 17 :!:. 16 . 6 
(r ange) (4-64) ( 4-64) 
Wildebeest 107 73 68 65 64 
Haan :!:. SD 59 :!:. 57 . 5 3.9;!:.61.7 
( range) (4-256) (4-256) 
Bunters hartabeest 4 0 ND 0 0 
Mean :!:. SD <4 <4 
(range) 
Blesbok 1 0 ND 0 0 
Mean ! SD <4 <4 
(range) 
subfamily Bippotraginae 
Addax 35 8 7 6 4 
Mean :!:. SD 5 .7 :!:. 2.0 7.5 :!:. 3 . 4 
( range) (4-8) (4-16) 
Screen ELI SA 
number neg 
WCll anti ge n 
216 
0.060 i 0.018 
(0.0 14-0.097) 
15 
0.040 i 0.016 
( 0 . 016-0.075) 
30 
0.052 i 0.015 
(0. 031- 0.0 95 ) 
15 
0 . 06 3 i 0. 017 





0.254 i 0. 129 
(0. 117-0 .618) 
1 
0 . 069 i 0.0 17 0. 126 i 0.0 
(0.0 42- 0.098) 
11 
0.0 44 i 0.009 
(0 . 0 23- 0.0 6 2) 
7 
0.0 53 i 0.015 
(0. 0 24-0 . 071) 
l 
o.o5o i a . a 
5 
0.066 i 0.044 
(0.008-0.111) 
37 
0 .0 44 i 0.016 
(0.0 12-0 .083) 
4 
0.037 i 0 . 006 
(0.029-0.0 43 ) 
1 
0.03 8 i 0 . 0 
27 
0 .0 46 i 0.014 
(0.017-0.096) 
21 
0. 267 i 0.0 74 
(0 . 166 -0 . 419 ) 
70 
0.429 i 0.161 
(0. 161-0.995 ) 
8 
0.2 44 i 0.0 48 
(0 . 173 - 0.342) 
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Verification Enzyme-Linked Immunosorbent Assay 
number neg 
WCll antigen NHC ant i gen 
0. 174 i 0 . 075 
(0.108 -0 . 378 ) 
0.155 i 0 . 0 
11 
1 
0. 160 i 0.07 2 
(0.097-0 . 365) 
0 . 118 i 0.0 
number pos 
WCll antigen NHC antig 
24 
0.259 i 0.107 0 .0 56 i 0 
(0. 113-0 . 4 50) ( 0.031-0. 
21 
0.23 6 i 0.060 0.020 i 0 
co. 165-0.392> co.0 12-0. 
70 
0 . 430 i 0. 163 
(0 . 167-0 . 932 ) 
0.261 i 0 . 053 
(0. 178-0 .359 ) 
8 
0.0 53 i 0 
(0 . 002-0. 
0.060 i 0 
(0.019 - 0. 
Table ?. (continued) 
Serologi c Assays 
IFA IFA IG30359 WCll 
Family Number 1 : 20 1 : 100 VN VN 
subfamily o! number number number number 
species anima l s p o s pos pos pos 
subfamily Bippo traginae . 
Sable antelope 26 0 0 0 
Me an ±. SD <4 <4 
(range) 
Scimitar-ho rned oryx 2 2 2 2 2 
Mean ±. SD 10 ±. 8 . 5 10 ±. 8 . 5 
( range ) ( 4-16) ( 4-16 ) 
Balsa oryx 6 6 6 6 
Hean ±. SD 24 ±. 12 . 4 33 ±. 25 
( range ) ( 8-32 ) ( 4 - 64 ) 
Gems bolt 15 2 l l l 
Mean ±. SD 16 24 
( range) 
Fringe-eared oryx l 0 ND 0 0 
Hean ±. SD <4 <4 
( range ) 
Ar ab ian oryx 11 2 l l l 
Hean ±. SD 16 32 
(range) 
subfamily Antilopinae 
Blac ltbu ck 2 l l l l 
Hean ±. SD 8 8 
( range ) 
Grants gaze lle 30 0 ND 0 0 
Mean ±. SD <4 <4 
( range) 
Thomaons gazelle 2 0 ND NTb NT 
Mean ±. SD 
(range ) 
Pers i an gazelle 9 0 ND 0 0 
Mean ±. SD <4 <4 
( range ) 
Dama gazelle 5 0 ND 0 0 
Hean ±. SD <4 <4 
( range ) 
Spelt es gazelle l 0 ND 0 0 
Mean ±. SD NTIS <4 
Suni l 0 ND 0 0 
Hean ±. SD <4 <4 





0.057 !:. 0.015 
(0.02 4-0.89) 
1 
0.044 !:. 0 . 0 
13 
0.038 !:. 0.011 
(0.0 23-0 . 072) 
1 
0.069 !:. 0.0 
10 
0.045 !:. 0.015 
(0.024-0.067) 
1 
0.083 !:. 0.0 
30 
0.052 !:. 0.013 
(0.011 -0 .082) 
1 
0.036 !:. 0 . 0 
9 
0.036 !:. 0.01 
(0.022-0.061) 
5 
0.037 !:. 0.012 
( 0. 025-0. 057) 
0 . 028 !:. 0 . 0 
l 





0.136 !:. 0.0 
2 
0.228 !:. 0.018 
(0.215-0. 240 ) 
6 
0.43 4 !:. 0 .143 
(0.237-0.592) 
2 
0.2 47 !:. 0.127 
(0. 157-0.349) 
1 
0.449 !:. 0.0 
0.189 !:. 0.0 
1 
0. 145 !:. 0.0 
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Verificati on Enzyme-Linked Immunosorbent Assay 
number neg number pas 
WCll antigen NHC antigen WCll antigen NHC antig 
0.117 !:. 0.0 0.032 !:. 0 
2 
0.211 !:. 0.016 0.029 !:. 0 
(0.199 - 0.222) 
6 
0.420 !:. 0.131 0.035 !:. 0 
(0.250-0.531) (0.022-0 . 
2 
0.237 !:. 0. 144 0.024 !:. 0 
(0.135 -0 .372) (0.016-0. 
1 
0.434 !:. 0.0 0.026 !:. 0 
1 
0. 212 !:. 0.0 0.016 !:. 0 
l 
0.130 !:. 0.0 0 .023 !:. 0 
Table z. (continued) 
Serologic Assays 
IFA IFA IG30359 WCll 
Family Number 1 : 20 l : 100 VN VN 
s u bfamily o! number number number number 
s12ecies animals J20 S J2 0 S J20S J20S 
subfamily Caprinae 
Aoudad / Barbary sheep 3 0 ND 0 0 
Mean ;t SD <4 <4 
(range) 
Markhor 28 s 2 0 0 
Mean ;t SD <4 <4 
(range) 
Nubian ibex 35 27 11 2 2 
Mean ;t SD 6 :t 2 . 8 6 :t 2 . 8 
(range) ( 4-8) ( 4-8 ) 
Domestic goat so 18 14 2 1 
Mean ;t SD 6 :t 2 . 8 4 
(range) ( 4-8 ) 
African pygmy goet 37 s 3 0 0 
Mean ;t SD <4 <4 
( range) 
Four horn sheep 7 0 ND 0 0 
Mean ;t SD <4 <4 
(range) 
Lincoln lamb 1 0 ND 0 0 
Mean ;t SD <4 <4 
(range) 
Dalla sheep 3 0 ND 0 0 . 
Mean ;t SD <4 <4 
(range) 
Mouflon 6 2 l 0 0 
Mean ;t SD <4 <4 
(range ) 
Domestic sheep 49 1 7 7 s 6 
Mean ;t SD 29 :t 55.5 25 :t 50 . 6 
( range) ( 4-128 ) ( 4-128 ) 
Chamois 17 2 2 0 0 
Mean ;t SD <4 <4 
(range) 
Saiga antelope s 0 ND 0 0 




WCll anti g en 
3 
0.071 ± 0.024 
(0.054-0.099) 
2 2 
0.052 ± 0.023 
(0.023 - 0. 102) 
9 






0. 2 37 ± 0.051 
(0. 1 51 - 0.289) 
26 
0.235 ± 0.093 
(0.119-0.477) 
13 
0.065 ± 0.040 0.239 ± 0 . 097 
(0.017-0.146) (0.134-0.516) 
36 1 
0.041 ± 0.0 2 5 0.446 ± 0.0 
(0 . 013-0. 121) 
7 
0 . 0 43 ± 0.0 13 
(0 . 028-0.060) 
1 
0.088 ± 0.0 
3 
0.081 ± 0.013 
(0.066 - 0.090) 
4 
0.097 ± 0.026 
(0. 074-0 .133) 
32 
0.116 ± 0.032 
(0.056-0.170) 
1 4 
0.055 ± 0.018 
(0 . 021-0.086) 
5 
0 . 040 ± 0.012 
0.029-0.061 
2 
0.289 ± 0.055 
(0.250 - 0 .3 28 ) 
1 7 
0.288 ± 0.090 
(0.184-0.507) 
3 
0.291 ± 0.061 
(0.221- 0.333) 
83 
Ver i fication Enzyme -Li nk e d Immunosorbent Assay 
number n e g 
WCll anti g en NHC anti g en 
n umber pos 
WCl l antigen 
0 . 2 13 ± 0.082 
(0. 136-0.353) 
0.242 ± 0.086 
(0 . 126 - 0. 465 ) 
NHC antig 
6 
0.027 ± 0 
(0 . 022 - 0. 
26 
13 
0.034 ± 0 
(0.024-0. 
0.308 ± 0.083 0.066 ± 0 
(0 . 186-0.505) (0.037-0. 
1 
0 . 429 ± 0.0 0.100 ± 0 
2 
0.263 ± 0.018 0.046 ± 0 
(0.250-0.275) (0.030-0. 
17 
0.308 ± 0.10 4 0 .05 4 ± 0 
(0. 140-0 .515) (0.011-0 . 
3 
0.270 ± 0.051 0 .023 ± 0 
(0.240-0.329) (0.020-0. 
84 
the virus neutralization assay is presented in Table 9. The calculated 
sensitivity of the immunofluorescence assay, compared with that of the 
virus neutralization, was 99.1%. The specificity of the !FA was 87.6%. 
The calculated sensitivity of the virus neutralization, compared with that 
of the indirect immunofluorescence assay, was 49.8%. The specificity of 
the VN was 99 . 9%. Comparison of the indirect immunofluorescence assay and 
the enzyme-linked immunosorbent assay is presented in Table 10. The 
calculated sensitivity of the indirect immunofluorescence assay, compared 
with that of the enzyme-linked immunosorbent assay, was 96.3% . The 
specificity of the !FA was 97.0%. The calculated sensitivity of the 
enzyme-linked immunosorbent assay, compared with that of the indirect 
immunofluorescence assay, was 89.0%. The specificity of the ELISA was 
99 . 1%. Comparison of the enzyme-linked immunosorbent assay and the virus 
neutralization is presented in Table 11. The calculated sensitivity of 
the enzyme-linked immunosorbent assay, compared with that of the virus 
neutralization , was 98.3%. The specificity of the ELISA was 89.7%. The 
calculated sensitivity of the v irus neutralization assay, compared with 
the enzyme-linked immunosorbent assay, was 54.0%. The specificity of the 
VN was 99.8%. 
Table 8. Comparison of serologic techniques for the detection of 














Camel (Camelus sp.) 
Lama 
Llama ( Lama glama glama ) 


















Reeves muntjac (Muntiacus reevesi) 25 1 7 
Cervinae 
Cervus 
Elds deer (Cervus eldi thamin) 2 2 
Formosan sika deer (Cervus nippon taiwanus) 6 5 
Brown elk (Cervus elaphus) 1 1 
Tule elk (Cervus elaphus nannodes ) 1 1 
Barasingha (Cervus duvauceli) 8 7 
Axis deer (Cervus axis) 3 3 
Elaphurus 
Pere Davids deer (Elaphurus davidanus) 4 4 
Odoco ileinae 
Hy dropotes 
Chinese water deer ( Hydropotes inermis) 2 2 
Odocoileus 
White-tailed deer (Odocoileus virginianus) 95 92 
Rangifer 
Reindeer (Rangifer tarandus) 7 7 
aIFA - indirect immunofluorescence assay. 
bVN - virus neutralization assay; Neg - negative; Pos - positive. 
cELISA - screen enzyme-linked immunosorbent Assay. 
















































































































































































































Species (Scientific Name) 
Giraffidae 
Giraffa 
Giraffe (Giraffa camelopardalis) 
Okapi a 
Okapi (Okapia johnstoni) 
Antilocapridae 
Antilocapra 




American bison (Bison bison) 
European bison,IWisent (Bison bonasus) 
Bos 
Indian gaur (Bos gaurus) 
Ankole (Bos taurus) 
Banteng (Bos javanicus) 
Scottish highland cattle (Bos taurus) 
Yak (Bos mutus) 
Domestic cattle (Bos taurus) 
Syncerus 
Cape buffalo (Syncerus caffer caffer) 
Taurotragus 
Eland (Taurotragus oryx) 
Tragelaphus 
Nyala (Tragelaphus angasi) 
Sitatunga (Tragelaphus spekei) 
Greater kudu (Tragelaphus strepsiceros) 
Reduncinae 
Kobus 
Waterbuck (Kobus ellipsiprymnus) 
Nile lechwe (Kobus megaceros) 
Alcelaphinae 
Alcelaphus 
Hartebeest (Alcelaphus buselaphus) 
Connochaetes 
Wildebeest (Connochaetes sp.) 
Damaliscus 
Hunters hartebeest (Damaliscus hunteri) 




















































!FA Negative !FA Positive 
VN Neg VN Toxic VN Pos VN Neg VN Toxic VN Pos 
ELISA ELISA ELISA ELISA ELISA ELISA 
Neg Pos Neg Pos Neg Neg Pos Pos Neg Pos 
Ver Ver Ver Ver Ve r 
Neg Pos Pos Pos Pos Pos 
2 0 0 0 0 0 0 0 0 0 0 
1 0 0 0 0 0 0 0 0 0 0 
0 0 0 0 0 0 1 0 0 0 0 
10 1 0 0 0 0 0 1 0 0 0 
5 0 0 0 0 0 0 0 0 0 0 
10 0 0 0 0 0 2 2 0 0 0 
3 1 0 0 0 0 0 0 0 0 0 
11 0 0 0 0 0 0 0 0 0 0 
1 0 0 0 0 0 0 1 0 0 0 
2 0 0 0 0 0 0 0 0 0 0 
20 7 11 0 7 0 0 2 18 0 0 6 
1 5 0 0 0 0 0 0 0 0 0 0 
30 0 0 0 0 0 0 0 0 0 0 
15 0 0 0 0 0 0 0 0 0 0 
20 1 0 0 0 0 0 0 0 0 0 
11 0 0 0 0 0 0 0 0 0 0 
7 0 0 0 0 0 0 0 0 0 0 
1 0 0 0 0 0 0 0 0 0 0 
3 0 0 0 0 0 2 3 0 0 18 
34 0 0 0 0 0 3 6 0 0 64 
4 0 0 0 0 0 0 0 0 0 0 
1 0 0 0 0 0 0 0 0 0 0 





Species (Scientific Name) 
Hippotraginae 
Addax 
Addax (Addax nasomaculatus) 
Hippotragus 
Sable antelope (Hippotragus niger ) 
Oryx 
Scimitar-horned oryx (Oryx dammah) 
Beisa oryx (Oryx gazella beisa) 
Gemsbok (Oryx gazella gazella) 
Fringe-eared oryx (Oryx gazella callotis) 
Arabian oryx (Oryx leucoryx) 
Antilopinae 
Antilope 
Blackbuck (Antilope cervicapra) 
Gazella 
Grants gazelle (Gazella granti) 
Thomsons gazelle (Gazella thomsoni) 
Persian gazelle (Gazella subgutturosa) 
Dama gazelle (Gazella dama) 
Spekes gazelle (Gazella spekei) 
Neotragus 
Suni (Neotragus moschatus) 
Caprinae 
Ammotragus 
Aoudad/Barba ry sheep (Ammotragus lervia) 
Capra 
Markhor (Capra falconeri) 
Nubian ibex (Capra ibex nubiana) 
Domestic goat (Capra hircus ) 
African pygmy goat (Capra aegagrus hircus) 
Ovis 
Four horn sheep (Ovis sp,) 
Lincoln lamb (Ovis sp.) 
Dalls sheep (Ovis dalli) 
Mouflon (Ovis musimon) 
Domestic sheep (Ovis aries) 
Rupicapra 
Totals 
Chamois (Rupicapra rupicapra) 
Saiga 
































!FA Negative !FA Positive 
VN Neg VN Toxic VN Pos VN Neg VN Toxic VN Pos 
ELISA ELISA ELISA ELISA ELISA ELISA 
Neg Pos Neg Pos Neg Neg Pos Pos Neg Pos 
Ver Ver Ver Ver Ve r 
Neg Pos Pos Pos Pos Pos 
27 0 0 0 0 0 0 4 0 0 4 
25 0 0 0 0 0 0 1 0 0 0 
0 0 0 0 0 0 0 0 0 0 2 
1 0 0 0 0 0 0 0 0 0 6 
13 0 0 0 0 0 0 1 0 0 1 
1 0 0 0 0 0 0 0 0 0 0 
9 0 0 0 0 0 1 0 0 0 1 
1 0 0 0 0 0 0 0 0 0 1 
30 0 0 0 0 0 0 0 0 0 0 
0 0 0 1 1 0 0 0 0 0 0 
9 0 0 0 0 0 0 0 0 0 0 
5 0 0 0 0 0 0 0 0 0 0 
1 0 0 0 0 0 0 0 0 0 0 
1 0 0 0 0 0 0 0 0 0 0 
3 0 0 0 0 0 0 0 0 0 0 
21 0 2 0 0 0 1 3 1 0 0 
8 0 0 0 0 0 1 24 0 0 2 
32 0 0 0 0 0 5 10 2 0 1 
30 0 0 2 0 0 4 1 0 0 0 
7 0 0 0 0 0 0 0 0 0 0 
1 0 0 0 0 0 0 0 0 0 0 
3 0 0 0 0 0 0 0 0 0 0 
4 0 0 0 0 0 0 2 0 0 0 
29 0 2 0 0 1 1 11 0 1 4 
14 0 1 0 0 0 0 2 0 0 0 
5 0 0 0 0 0 0 0 0 0 0 
803 14 6 27 2 1 25 91 5 1 114 
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Table 9 . Comparison of the indirect immunofluorescence assay and virus 
neu tra l ization assay in the detection of antibodies to 
a l celaphine herpesvirus- 1 
Number of sera 
tested by the virus 




not detected (939) 
Sera toxic to 
tissue cultures (34) 
Calculationsc: 
Number of sera tested by the 
indirect immunofluorescence assay (IFA) 
Antibodies Antibodies 





Sensitivity of VN compared to t h e IFA - 116 - 1 
231 
x 100 - 49 . 8% 
Specificity of VN compared to the IFA - 939 - 116 x 100 - 99.9% 
824 
Sensitivity of I FA compared to the VN - 231 - 116 x 100 - 99.1% 
116 
Specificity of IFA compared to the VN - 824 - 1 
939 
x 100 - 87.6% 
aTiter > 1:20. Total number of ser a in parentheses. 
bTiter > 1:4 . 
csera toxic to tissue cultures were not used in calculations of 
sensitivity and specificity. 
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Table 10. Comparison of the indirect immunofluorescence assay and 
enzyme-linked immunosorbent assay in the detection of 
antibodies to alcelaphine herpesvirus - 1 
Number of sera tested by the 
indirect immunofluorescence assay (IFA) 
Number of sera tested 
by the enzyme-linked 




not detected (871) 
Calculations: 
Antibodies Antibodies 




Sensitivity of ELISA compared to the IFA - 218 - 8 x 100 = 89.0% 
236 
Specificity of ELISA compared to the IFA - 871 - 26 x 100 - 99.1% 
853 
Sensitivity of IFA compared to the ELISA - 236 - 26 x 100 = 96.3% 
218 
Specificity of IFA compared to the ELISA = 853 - 8 x 100 
871 
aTiter > 1:20. Total number of sera in parentheses. 
97.0% 
bPositive serum had a mean absorbance (405/450 nm) value greater than 
the 50% positive threshold absorbance value, and a signal to noise ratio 
greater than 1.8. 
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Table 11. Comparison of the enzyme-linked immunosorbent assay and virus 
neutralization assay in the detection of antibodies to 
alcelaphine herpesvirus-1 
Number of sera tested by the 
enzyme-linked immunosorbent assay (ELISA) 
Number of sera 
tested by the virus 




not detected (939) 
Sera toxic to 













Sensitivity of VN compared to the ELISA - 116 - 2 x 100 
211 
54 .0% 
Specificity of VN compared to the ELISA - 939 - 97 x 100 = 99.8% 
844 
Sensitivity of ELISA compared to the VN - 211 - 97 x 100 - 98.3% 
116 
Specificity of ELISA compared to the VN = 844 - 2 x 100 
939 
89.7% 
aPositive serum had a mean absorbance (405/450 nm) value greater than 
the 50% positive threshold absorbance value, and a signal to noise r atio 
greater than 1.8; Total number of sera in parentheses. 
bTiter ~ 1:4. 
csera toxic to tissue cultures were not used in calculations of 
sensitivity and specificity. 
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DISCUSSION 
In order to provide laboratory diagnostic assistance for MCF 
diagnosis, three serologic assays, the indirect immunofluorescence assay, 
the virus neutralization assay, and the enzyme-linked immunosorbent assay 
were compared for detection of antibodies to MCF virus in clinically 
affected animals with either epidemiological form of the disease, and in 
potential reservoir host species. 
A fourth serologic assay, the complement fixation assay, was 
unsuccessful in detecting MCF complement fixing antibodies in sera from 
clinically affected animals, reservoir host species, or in either of the 
two calves (calf 9471, GC #16) used to follow MCF antibody development 
secondary to intravenous inoculation with the WCll strain of AHV-1 . 
Failure of the CF assay could have several plausible explanations. 
Insufficient antigen or inadequate antigenic mass may have resulted in the 
formation of insufficient quantities of antigen-antibody complexes to fix 
the first component of complement and initiate the classical pathway of 
complement fixation. Complement fixing antibodies may not have been 
present in the sera at levels that could be detected by the CF assay used 
in this study . The use of a less stringent CF assay such as that 
described by Kalunda (1975) or Hamdy et al. (1980) may have had better 
success, but even these CF assays failed to detect complement fixing 
antibodies prior to development of neutralizing antibodies. Bovine IgGl 
and IgM are the only bovine immunogobulins capable of fixing guinea pig 
complement, but even these immunoglobulins have a low complement fixing 
efficiency. Excess levels of noncomplement fixing antibodies in these 
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sera may have inhibited the formation of antigen-antibody complexes thus 
preventing complement fixation. Anticomplementary activity of the test 
sera did not appear to be a contributing factor as the serum controls 
reacted appropriately in all of the CF assays completed. The use of a 
modifying factor in the AHV-1 CF assay was not investigated. Review of 
the literature on the use of the CF assay for detection of MCF antibodies 
found the assay to be less sensitive then either the IFA or the VN 
(Kalunda, 1975; Hamdy et al., 1980). Further work on the CF assay was not 
done. 
The indirect immunofluorescence assay was shown to have the greatest 
sensitivity for detection of antibodies directed against MCF virus, with 
calculated sensitivities of 99.1% as compared to the VN, and 96.3% as 
compared to the ELISA . The IFA detected antibodies agains t AHV-1 antigens 
in clinically affected animals with either epidemiological form of the 
disease earlier and with higher titers than the VN assay. This finding 
was in agreement with Rossiter et al. (1977) who had previously reported 
that antibodies against AHV-1 virus could be detected earlier and with 
higher titers by the IFA than by the VN in cattle and rabbits 
experimentally infected with AHV-1. Rossiter et al. (1977) hypothesized 
that antibodies detected by the IFA were not directed against the same 
surface viral antigens as neutralizing antibodies, but were directed 
against viral antigens expressed earlier in the disease process. Rossiter 
(1983) demonstrated IFA antibodies to the AHV-1 virus in cattle with 
histopathologically confirmed cases of sheep-goat-associated MCF. He 
hypothesized that the etiological agent of the sheep-goat-associated form 
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is antigenically related to the AHV-1 group of viruses . Other 
investigators have also reported on the presence of IFA antibodies to the 
AHV-1 virus in cattle with sheep-goat-associated MCF (Harkness 1985 ; 
Heuschele et al., 1984a) . The pattern of specific IFA fluorescence is the 
same using sera from either epidemiological form of the disease, making it 
impossible to distinguish the epidemiological forms on the basis of IFA 
serology. Advantages of the IFA include minimal maintenance, short assay 
time , high degree of sensitivity for detection of MCF antibodies , and 
strong negative correlation with the VN and ELISA. Large numbers of WCll 
infected cover slips can be prepared and stored at -70C for over 12 months 
without loss of viral antigen reactivity. Readily visible WCll viral cpe 
in the cell monolayers of infected coverslips makes it easy to detect 
uninfected cover slips, thus eliminating false negative results. The IFA 
procedure can be completed in three to four hours. The strong negative 
correlation (>99%) between the three assays, along with the high degree of 
sensitivity for detection of antibodies makes this assay the assay of 
choice for screening large numbers of animals for antibodies to MCF virus. 
IFA negative animals can be reported as seronegative with a high degree of 
confidence. The IFA would work well for laboratories which have limited 
capabilites to maintain cell cultures. It would also be the assay of 
choice for laboratories which do not want to expend a lot of time or money 
on MCF diagnosis, but want to employ a simple serologic assay to assist 
field veterinarians in diagnosing MCF . Disadvantages of the IFA assay 
include, antigenic cross reactivity with other bovine herpesvires, the 
need to determine the appropriate anti-species IFA conjugate for use with 
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each species being tested, and subjective differentiation of specific 
fluorescence from nonspecific fluorescence in the cell monolayers of 
infected cover slips. Antigenic cross reactivity of the WCll IFA antigens 
with antisera produced against BHV-3 was detected in this study . The 
antigenic cross reactivity was unidirectional, as no cross reactivity 
between BHV-3 viral antigens and hyperimmune antisera produced against 
AHV-1 viruses were detected at the 1:20 serum dilution. The 
unidirectional cross reactivity makes it possible to use BHV-3 infected 
coverslips to identify BHV-3 positive antisera which have the potential of 
cross reactivity with the AHV-1 viral antigens. Antigenic cross 
reactivity among AHV - 1, BHV-1 and BHV-2 (Rossiter et al., 1977; Heuschele , 
1982; Rossiter, 1983; Osorio et al., 1985) has also been reported to 
occur, but was not demonstrated in this study . Potential antigenic cross 
reactivity among AHV-1, unrecognized sheep and goat herpesviruses, and 
bovine cytomegalovirus detected by the IFA will need to be evaluated as 
isolates become available . The degree of antigenic relationship between 
the sheep-goat-associated etiological agent and the AHV-1 group will be 
able to be determined only after the causative agent for the 
sheep-goat-associated MCF has been identified and characterized. The 
double diffusion technique demonstrated precipitin lines of complete or 
partial identity between bovine IgG and the immunoglobulins of most of the 
ruminants of the family Bovidae, family Cervidae, family Giraffidae, and 
family Antilocapridae making it possible to use anti-bovine IFA conjugate 
with these families. Sera from IFA positive animals were tested by the VN 
and the ELISA to confirm the serologic status of the animal. Nonspecific 
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fluorescence of the WCll infected BT monolayers could be mistaken for 
specific fluorescence by inexperienced readers causing false positive IFA 
results. 
The enzyme-linked immunosorbent assay was second in sensitivity for 
detection of antibodies to MCF virus with calculated sensitivities as 
compared to the IFA of 89.0%, and as compared to the VN of 98.3% . The 
ELISA assay detected antibodies against the WCll solubilized antigen in 
clinically affected animals with either epidemiological form of the 
disease. This concurred with the findings of Wan and Castro (1986) with 
their AHV-1 ELISA. Two hundred and forty sera could be screened for the 
presence of MCF antibodies in approximately five hours. Antigenic cross 
reactivity of the WCll ELISA antigen with antisera produced against other 
bovine herpesviruses were not seen. This again was in agreement with the 
findings of Wan and Castro (1986). This lack of antigenic cross 
reactivity makes the ELISA more specific than the IFA assay . Potential 
antigenic cross reactivity with unrecognized sheep and goat herpesviruses 
and bovine cytomegalovirus remains to be evaluated as isolates become 
available. The range of the ELISA absorbance values was from 0.007 to 
1.072, with the majority of the absorbance values under 0.500. The low 
specific ELISA absorbance values seen in this assay can be attributed 
primarily to two factors, the marginal antigenic mass of the ELISA 
antigen, and secondly the cell-associated nature of the virus which 
results in delayed antibody development and lower specific antibody titers 
than generally noted with most herpesviruses. The specific ELISA 
absorbance values for exotic species were also affected by the relative 
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binding affinity of the RAB ELISA conjugate for exotic species 
immunoglobulins . The late seroconversion of gnotobiotic calf #16 by the 
ELISA ( day 28) represents a phenomenon commonly seen with gnotobiotic sera 
used in ELISA assays. Lack of normal background immunoglobulins in the 
gnotobiotic serum results in low absorbance values even when high specific 
antibody titers are present as detected by other serologic assays. It has 
been hypothesized that specific antigen-antibody reactions incorporate 
normal background immunoglobulins into the ELISA reactions system thus 
intensifying the colormetric reaction. In the gnotobiotic sera adequate 
background immunoglobulins are not present to facilitate the reaction thus 
accounting for the lower absorbance values . Falsely elevated ELISA 
absorbance values were seen with bacterially contaminated antisera, sera 
with severe hemolysis , and in serum with antibodies directed against h ost 
cell proteins. These were differentialed from the true ELISA positives by 
use of the verification ELISA. The ELISA assay requires more time and 
equipment to maintain as compared to the requirements for the other 
serologic assays. Enzyme-linked immunosorbent assay microplates needed to 
be coated at least two days prior to use. Buffers and solutions needed to 
be properly maintained. The appropriate anti-species horseradish 
peroxidase-labeled conjugate and the optimal conjugate dilution have to be 
determined for each species tested. Production of monoclonal antibodies 
directed against the WCll virus and conversion of the ELISA assay to a 
competitive ELISA would eliminate many of the current disadvantages of the 
ELISA system. Sera from species of the family Equidae and family 
Camelidae did not demonstrate identity with bovine IgG. Validity of the 
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ELISA results for these species could therefore be questioned. The ELISA 
is the assay of choice for confirmation of IFA positives as it is a rapid 
specific assay that can be used to detect antibodies against AHV-1 
antigens from either epidemiological form of the disease. This assay 
could be used to eliminate potential reservoir hosts from valuable 
zoological collections, and as a diagnostic tool to assist with the 
diagnosis of both epidemiological forms of the disease when the 
serological findings are taken along with epidemiological information, 
c linical signs, gross l esions, and histopathological lesions to complete 
the diagnostic picture. The use of this assay would probably be limited 
to well equipped laboratories and research laboratories willing to spend 
the time necessary to ma intain this assay. 
The virus neutralization assay, was the least sensitive of the three 
assays, with calculated sensitivites for the WCll VN of 54.0% as compared 
to the ELISA, and 49.8% and compared to the IFA. The assay is generally 
considere d the most specific assay for detection of antibodies directed 
against MCF virus (Heuschele et al., 1984a). The WCll VN had a calculated 
specificity of 99 . 9% as compared to the IFA, and 99.8% as compared to the 
ELISA. Neutralizing antibodies are rarely detected in clinically affected 
cattle with either epidemiological form of the disease (Plowright, 1968; 
Kalunda, 1975; Rossiter et al ., 1977; Heuschele et al., 1984a; Wan and 
Castro, 1986) . Neutralizing antibodies can be readily detected in 
reservoir hosts of the AHV-1 v irus , but are rarely detected in reservoir 
hosts of the sheep-goat-associated MCF. Malignant catarrhal fever 
neutralizing antibodies were detected in 116 ( 10. 7%) of the animals by the 
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WCll VN, and 119 (10.9%) of the animals by the IG30359 VN with the 
majority of the VN positive animals being clinically normal exotic species 
primarily of the subfamily Alcelaphinae and subfamily Hippotraginae. The 
difference between the number of seropositive animals detected by the two 
VN assays was most likely related to variance in test dose virus between 
the assays, and not r eflective of MCF strain difference, as antibody 
titers were shown by Mushi and Plowright (1979) to have a strong 
correlation to the level of test dose virus used. Individual animals 
considered seropositive by one VN and negative by the other generally had 
antibody titers that variedby only a two-fold serum dilution. This would 
appear to support the idea of a single serotype for the AHV-1 group of 
viruses as hypothesized by Rossiter et al. (1977). Thirty-four sera 
tested were toxic for cell cultures and therefore could not be tested 
(NT) . Antigenic cross reactivity of the WCll virus with antisera produced 
against BHV 1-3 and PHV-1 by virus neutralization was not demonstrated in 
this study. This agreed with the previous findings of Kalunda (1975), 
Heuschele (1982), and Hamblin and He dger (1984). Potential antigenic 
cross reactiv ity with unrecognized sheep and goat herpesviruses and bovine 
cytomegalovirus remain to be evaluated as isolates become available. 
Addition of guinea pig complement to the serum virus mixture prior to 
neutralization did not enhance neutraliztion (Rossiter et al . , 1977). In 
this study, serum from clinically affected animals occasionally 
demonstrated enhanced neutralization titers when they were tested without 
heat inactivation. This may be due to enhanced neutralization of the 
AHV-1 virus in the presence of bovine compl ement, which is a normal 
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component of sera destroyed by heat inactivation. The addition of a 
standard amount of bovine complement to the VN system prior to 
neutralization, if a source of readily available bovine complement could 
be found, might enhance the neutralization titers in clincally affected 
animals. Disadvantages to the VN assay include the need for maintenance 
of tissue cultures, and failure of the assay to detect antibodies in most 
clinically affected animals . The VN also rarely detects antibodies 
against the sheep-goat-associated form of MCF. One hypothesis is that 
antigenic differences between the AHV-1 group of viruses and the 
etiological agent of the sheep - goat-associated form of MCF may account for 
the failure of the AHV-1 VN assays to de tect neutralizating antibodies 
against the sheep-goat-associated form. This will have to be proven when 
the etiological agent is finally isolated. 
Direct comparison of the serologic assays demonstrated a strong 
negative correlation between the three assay(> 99%). A strong positive 
correlation was demonstrated between the IFA and ELISA (96 . 3%). Sera 
tested positive by the VN were positive by the IFA and ELISA assays in 
greater than 98% of the sera. The VN failed to confirm IFA positive test 
results in 50.2% of the sera. The majority of the IFA postive sera that 
were SVN negative were either from clinically affected animals, or from 
species of the subfamily Caprinae. Separation of the epidemiological 
forms of MCF, and the development of specific serological assays for the 
sheep-goat-associated MCF will be accomplished only with the advent of the 
isolation and identification of the causative agent. 
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Conclusion 
The serologic assays described in this study can be used to detect 
antibodies against MCF virus. The indirect immunofluorescence assay had 
the greatest sensitivity for detection of antibodies in clinically 
affected animals with either epidemiological form of the disease. 
Antigenic cross reactivity between the IFA antigens and antisera against 
BHV-3 viruses, makes serodiagnosis by IFA alone questionable. The IFA 
assay is a valuable tool to rapidly screen large numbers of animals with a 
high degree of sensitivity for the presence of antibodies against MCF 
virus. The virus neutralization assay had the greatest specificity , but 
lowest sensitivity for antibody detection. Neutralizing antibodies were 
rarely detected in clinically affected animals. The primary value of the 
VN was its use for confirming the seropositive status of reservoir host 
species. The enzyme-linked immunosorbent assay appears to be the assay of 
choice for detection of antibodies to MCF virus. The sensitivity and 
specificity of the ELISA places it between the other assays with a greater 
sensitivity than the VN, and a higher degree of specificity than the IFA. 
Antigenic cross reactivity between the WCll ELISA antigen and antisera 
produced against BHV 1-3 were not demonstrated making the assay more 
reliable for serodiagnosis than the IFA. The ELISA detected antibodies in 
' clinically affected animals with either epidemiological forms of the 
disease, and readily detected the presence of antibodies in reservoir host 
species. The short assay time makes the ELISA the best assay for 
confirmation of positive IFA results. The use of one or more of the 
serological assays for detection of antibodies to MCF virus when taken 
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along with the epidemiological profile, clinical signs, gross lessions, 
and histopathologic lessions should markedly enhance MCF diagnosis, and 
provide valuable diagnostic assistance to field veterinarians, as well as 
provide valuable information to epidemiologists studying both forms of the 
disease . 
Summary 
Three serologic assays, the IFA, VN, and ELISA were compared for 
detection of MCF antibodies against either epidemiological form of the 
disease. Sera from 1089 animals representing 63 different species were 
tested by the three assays. The IFA was determined to be the most 
sensitive, but least specific assay. Antigenic cross reactivity between 
AHV-1 IFA antigens and bovine antisera produced against BHV-3 were 
demonstrated. The IFA detected 236 positive animals (21.7%) representing 
26 different species at the 1:20 serum dilution. The IFA detected 178 
positive animals (16 . 3%) representing 22 species at the 1:100 dilution. 
Antibodies against MCF virus were detected by the IFA in 
histopathologically confirmed cases of sheep-goat-associated MCF, in 
clinical cases of wildebeest-derived MCF, and in reservoir host species. 
The ELISA detected MCF antibodies in 218 animals (20 . 0%) representing 25 
different species. Antigenic cross reactivity between the WCll ELISA 
antigen and bovine antisera produced against BHV 1-3 were not 
demonstrated . The ELISA assay also detected antibodies in clinically 
affected animals with either epidemiological form of the disease. 
Seropositive reservoir host species were readily identified by the ELISA. 
The WCll VN was the least sensitive assay, detecting neutralizing 
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antibodies in 116 animals (10.7%) representing 15 different species. 
Antigenic cross reactivity between the WCll virus, and antisera produced 
against BHV 1-3 and PHV-1 were not demonstrated using the VN assay. 
Neutralizing antibodies against MCF virus were rarely detected in 
clinically affected animals. Neutralizing antibodies were rarely detected 
in histopathologically confirmed cases of sheep-goat-associated MCF. The 
ELISA appears to be the assay of choice for detection of antibodies 
against MCF when equipment and time to maintain the assay are available. 
All three serologic assays can be used for detection of MCF antibodies. 
Serologic assays will provide valuable diagnostic assistance in the 
diagnosis of malignant catarrhal fever, and provide valuable information 
for use in epidemiological studies of the disease. 
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APPENDIX I 
Transmission of Malignant Catarrhal Fever 
Wildebeest-derived malignant catarrhal fever: 
black wildebeest to cattle 
Mettam, 1923 (cited by Daubney and Hudson, 1936) 
blue wildebeest to.cattle 
Daubney and Hudson (1936) 
Plowright (1965b) 
Mushi and Wafula (1983) 
wildebeest to rabbit 
Mushi and Wafula (1983) 
hartebeest to cattle 
Reid and Rowe (1973) 
cattle to cattle 
Mettam, 1923 (cited by Daubney and Hudson, 1936) 
Daubney and Hudson (1936) 
Piercy, 1952a (cited by Plowright, 1968 ) 
Plowright (1965b) 
Orsborn et al. (1977) 
Kalunda et al. (198la) 
Whitenack et al. (1981) 
cattle to blue wildebeest 
Plowright (1965b) 
cattle to rabbit 
Daubney and Hudson (1936) 
Plowright, 1953 (cited by Plowright, 1968) 
Piercy, 1955 (cited by Hoffmann et al., 1984b) 
Orsborn et al. (1977) 
Edington et al., 1979 (cited by Edington and Patel, 1981) 
cattle to white-tailed deer 
Whitenack et al. (1981) 
cattle to neonatal sheep 
Kalunda (1975) 
gaur to cattle 
Whitenack et al. (1981) 
Castro et al. (1982) 
greater kudu to cattle 
Whitenack et al. (1981) 
Castro et al. (1982) 
sheep to cattle 
Kalunda (1975) 
rabbit to cattle 
Daubney and Hudson (1936) 
rabbit to rabbit 
Orsborn et al. (1977) 
rabbit to rat 
Jacoby et al. (1988) 
rabbit to neonatal guinea pig 
Jacoby et al. (1988) 
rabbit to neonatal hamster 
Jacpby et al. (1988) 
guinea pig to guinea pig 
Reid and Buxton (1985) 
hamster to hamster 
Reid and Buxton (1985) 
rat to rat 




Sheep-goat-associated malignant catarrhal fever: 
cattle to cattle 
Goetze and Liess, 1929 (c ited by Daubney and Hudson , 1936) 
Jacotot, 1932 (cited by Plowright, 1968) 
Rinjard , 1935 (cited by Plowright, 1968) 
Daubney and Hudson (1936) 
Magnusson, 1939 (cited by Plowright , 1968) 
Duncan and Pearson, 1956 (cited by Hoffmann et al., 1984b) 
Roderick, 1958 (cited by Plowright, 1968) 
Blood et al., 1960 (cited by Plowright, 1968) 
Pierson et al. (1974) 
Horner et al. (1975) 
Hamdy et al. (1978) 
Pierson et al. (1978) 
Liggitt et al., 1978 (cited by Liggitt and DeMartini, 1980) 
Selman et al. (1978) 
Pierson et al. (1979) 
Ramachandra et a l . (1982) 
Re id et al . (1986) 
cattle to bison 
Liggitt et al. (1980) 
cattle to rabbit 
Daubney, 1959 (cited by Buxton and Re id, 1980) 
Buxton and Reid (19 80 ) 
Reid et a l . (1986) 
swamp buffalo to cattle 
Mansjoer , 1957 (cited by Hoffma nn et al., 1984b) 
Hoffmann et al . (1984b ) 
swamp buffalo to rabbit 
Mans joer, 1957 (cited by Hoffmann et al., 1984b) 
rusa deer to rabbit 
Westbur y and Denholm (1982) 
red deer to r ed deer 
Oliver et al. (1983) 
Reid et a l . (1986) 
red dee r to roe deer 
Reid et a l. (1986) 
red deer to rabbit 
Buxton and Reid (1980) 
Reid et al. (1986) 
r ed deer to neonata l sheep 
Bux ton et al. (1985) 
rabbit to rabbit 
Buxton and Reid (1980) 
Westbury and Denholm (1982) 
Reid et al. ( 1986) 
rabbit to cattle 
Buxton and Reid (1980) 
rabbit to red deer 
Buxton and Re id (1980) 
Reid et al. (1986) 
rabbit to roe deer 
Reid et al . (1986) 
rabbit to hamster 
Reid et al . (1986) 
Jacoby et a l. (1988) 
hamster to hamste r 
Reid et al . (1986) 
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APPENDIX II 
Species with Reported Clinical Malignant Catarrhal Fever 









Axis deer (Cervus axis) AHV 
SGA 
Barasingha (Cervus duvauceli) AHV 
Elds deer (Cervus eldi thamin) AHV 
Luzon sambar deer (Cervus mariannus) AHV 
Malayan sambar deer (Cervus unicolor) AHV 
Rusa deer (Cervus timorensis) SGA 
Sika deer (Cervus nippon) SGA 
Formosan sika (C. nippon taiwanus) AHV 
Japanese sika (C, nippon nipQon) SGA 
Dybowski sika (C. ninnon dybowskii) AHV 
European red deer (Cervus elaQhus) SGA 
Elaphurus 








Colly ( 1977) 
Heuschele (1982) 
Colly ( 1977) 
Denholm and 
Westbury (1982) 
Wilson et al. (1983) 
Heuschele (1982) 
Heuschele et al. (1985b) 
Sanford et al. (1977) 
Sanford et al. (1977) 
Reid et al. (1979) 
McAllum et al. (1982) 




Huck et al. (1961) 
Tong et al. (1961) 
Senior et al. (1962) 
aAHV - alcelaphine herpesvirus; SGA - sheep-goat-associated 
malignant catarrhal fever; UNK - unkown; (?) - questionable 
diagnosis . 




Shiras moose (Alces alces shirasi) 
Capreolus 
Roe deer (Capreolus capreolus) 
Odocoileus 
Mule deer (Odocoileus hemionus) 









Williams et al. (1984) 
Reid and Buxton (1984) 
Pierson et al. (1974) 
Jessup (1985) 
Clark et al. ( 1970) 
Clark et al. ( 1972) 
Wobeser et al. (1973) 
Wyand et al. (1971) 
American bison (Bison bison) SGA Ruth et al. (1977) 
European bisonjWisent (Bison bonasus) AHV 
Bos 
Indian gaur (Bos gaurus) AHV 
Banteng (Bos javanicus) AHV 
SGA 
Watusi/Ankole (Bos taurus) AHV 
Domestic cattle (Bos taurus) AHV 
SGA 
Boselaphus 




Van Bekkum (1979) 
Ashton (1982) 
Hatkin (1980) 
Castro et al. (1981) 
Hatkin (1980) 
Ramachandra et al (1982) 
Hoffmann et al. (1984b ) 
Heuschele et al. (1984a) 
Mettam, 1923 (cited by 
Daubney and Hudson 
(1936) 
Daubney and Hudson 
(1936) 
Plowright (1964) 
Daubney and Hudson 
(1936) 
Murray and Blood (1961) 
Gray and Anthony (1969) 
Pierson et al. (19 73) 
Selman et al. (1974) 
James et al. (1975) 
Orsborn et al. (1977) 
Mare (1977) 








Water buffalo (Bubalus bubalis) 
Syncerus 
Cape buffalo (S. caffer caffer) 
Congo buffalo (S. caffer nanus) 
Tragelaphus 
Bongo (T. eurycerus isaaci) 
Bushbuck (Tragelaphus scriptus) 
Greater kudu (T. strepsiceros) 
Sitatunga (Tragelaphus spekei) 
Cephalophinae 
Cephalophus or Sylvicapra 
Duiker (species unknown) 
Alcelaphinae 
Alcelaphus 
Red hartebeest (A. buselaphus) 
Connochaetes 
Wildebeest (Connochaetes sp.) 
Damaliscus 
Blesbok (Damaliscus dorcas phillipsi) 
Hippotraginae 
Oryx 
Arabian oryx (Oryx leucoryx) 
















Ellipsen waterbuck (K. ellipsiprymnus) AHV 
Nile lechwe (Kobus lechwe) AHV 
Antilopinae 
Antilope 
Blackbuck (Antilope cervicapra) 
Gazella 
Slender horned gazelle (G. leptoceros ) 
Neotragus 
Zulu suni (N. moschatus zuluensis) 
Capri nae 
Hemitragus 
Nilgiri tahr (Hemitragus hylocrius) 
Ovis 






Parihar et al. ( 1975) 
Singh et al. (1979) 
Vanselow (1980) 
Hoffmann et al. (1984a) 
Ashton (1982) 
Pettit (1965) 
Heuschele ( 1982) (?) 
Colly (1977) 
Boever and Kurk (1974) 
Colly ( 1977) 




Colly (1977) (?) 
Ashton ( 1982) (?) 
Colly (1977) 
Heuschele ( 1982) 




Heuschele ( 1982) 
Heuschele (1982) 




Grumbein (1981) (?) 
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APPENDIX III 
Species from which Alcelaphine Herpesvirus (AHV) 
or AHV-like Virus has been Isolated 
Isolations from clinically normal animals: 
Connochaetes 
Blue wildebeest (Connochaetes taurinus taurinus)-Plowright et al. (1960) 
Whitebearded wildebeest 
(Connochaetes taurinus albojubatus)-Heuschele et al. (1984a) 
Whitetailed wildebeest (Connochaetes gnou)-Castro et al. (1981) 
Alcelaphus 
Cokes hartebeest (Alcelaphus buselaphus cokei)-Reid and Rowe (1973) 
Cape hartebeest (Alcelaphus buselaphus caama)-Heuschele et al. (1984a) 
Damaliscus 
Topi (Damaliscus lunatus korrigum)-Mushi et al. (198la) 
Jimela topi (Damaliscus lunatus jimela)-Heuschele et al. (1984a) 
Oryx 
Scimitar-horned oryx. (Oryx dammah)-Heuschele et al. (1984a) 
Capra 
Siberian ibex (Capra ibex sibirica)-Heuschele and Worley (1986) 
Isolations from animals with clinical malignant catarrhal fever: 
Cervus 
Formosan sika deer (Cervus nippon taiwanus)-Heuschele (1982) 
Axis deer (Cervus axis)-Heuschele (1982) 
Barasingha (Cervus duvauceli)-Heuschele (1982) 
Boselaphus 
Nilgai antelope (Boselaphus tragocamelus)-Heuschele (1982) 
Tragelaphus 
Greater kudu (Tragelaphus strepiceros)-Castro et al. (1981) 
Bos 
European bisonjWisent (Bos bonasus)-Straver and Van Bekkum (1979) 
Indian gaur (Bos gaurus)-Castro et al. (1981) 
Watusi/Ankole (Bos taurus)-Heuschele et al. (1984a) 
Domestic cattle (Bos taurus)-Plowright (1965b) 
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APPENDIX IV 
Species Tested Positive for Neutralizing Antibodies 




Hippopotamus (Hippopotamus amphibius)-Hamblin and Hedger (1984) 
(1:4 to 1 :45) 
Tragulidae 
Tragulus 




Reeves muntj ac (Muntiacus reevesi)-Heuschele et al. (1984a) 
(1:2 to 1:64) 
Cervinae 
Cervus 
Axis deer (Cervus axis)-Heuschele (1982) 
Elds deer (Cervus eldi thamin)-Heuschele et al. (1984a) 
(1:2 to 1:64) 
Formosan sika deer 
(Cervus nippon taiwanus)-Heuschele et al. (1984a) 
(1:2 to 1: 512) 
Giraffidae 
Giraffa 




American bison (Bison bison)-Heuschele (1982) 
Bos 
Indian gaur (Bos gaurus)-Heuschele (1982) 
Domestic cattle (Bos taurus)-Plowright (1968) 
(1:2 to 1: 256) 
Boselaphus 
Kalunda (1975) 
Rossiter et al. (1980) 
Heuschele et a l. (1984a) 
Nilgai (Boselaphus tragocamelus)-Heuschele (1982) 
Bubalus 
Water buffalo (Bubalus bubalis)-Heuschele et a l. (1984a) 
(1:2 to 1:3) 
Syncerus 
Cape buffalo (Syncerus caffer caffer)- Heuschele et al. (1984a) 
(1:2 to 1:8) 
Taurotragus 
Eland (Taurotragus oryx)-Heuschele (1982) 
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Tragelaphus 
Sitatunga (Tragelaphus spekei)-Heuschele et al. (1984a) 
(1 :2 to 1 : 8) 
Greater kudu 
(Tragelaphus strepsiceros)-Hamblin and Hedger (1984) 
(1:6 to 1:22) 
Hippotraginae 
Addax 
Addax (Addax nasomaculatus)-Heuschele et al. (1984a) 
(1:2 to 1:160) 
Hippotragus 
Roan antelope (Hippotragus eguinus)-Heuschele et al. (1984a) 
(1:2 to 1:6) 
Sable antelope (Hippotragus niger)-Hamblin and Hedger (1984) 
(1:4 to 1:32) 
Oryx 
Heuschele et al. (1984a) 
Barnard (1985) 
Scimitar-horned oryx (Oryx dammah)-Heuschele et al. (1984a) 
(1:2 to 1:256) 
Gemsbok (Oryx gaze lla gazella)-Hamblin and Hedger (1984) 
(1:4 to 1:45) 
Heuschele et al. (1984a) 
(1: 2 to 1: 256) 
Barnard (1985) 
Beisa oryx (Oryx gazella beisa)-Heuschele et al. (1984a) (1:2) 
Fringe-eared oryx 
(Oryx gazella callotis)-Reid et al. (1975) 
(1:2 to 1:256) 
Mushi and Karstad (1981) 
Heuschele et al. (1984a) 
Arabian oryx (Oryx leucoryx)-Heuschele et al. (1984a) 




(A. buselaphus caama)-Heuschele et al. (1984a) 
(1:4 to 1:256) 
Cokes hartebeest (A. buselaphus cokei)-Reid et al. (1975) 
Connochaetes 
Whitetailed wildebeest 
(Connochaetes gnou) -Ramsay et al. (1982) 
Heuschele et al.(1984a) 




(C. taurinus taurinus)-Plowright (1967) 
Kalunda (1975) 
Reid et al. (1975) 
Hamblin and Hedger (1984) 
(1:4 to 1 :256) 
Heuschele et al . (1984a) 
(1:12 to 1 :256) 
Barnard (1985) 
Whitebearded wildebeest 
(C. taurinus albojubatus)-Heuschele et al. (1984a) 
(1:2 to 1:256) 
Damaliscus 
Blesbok (Damaliscus dorcas phillipsi)-Heuschele et al. (1984a) 
(1:2 to 1 :6) 
Tsessebe (Damaliscus lunatus lunatus )-Hamblin and Hedger (1984) 
(1:4 to 1:16) 
Topi (Darnaliscus lunatus jimela)-Heuschele et al. (1984a) 
(1:2 to 1 :128) 




Lechwe (Kobus leche)-Hamblin and Hedger (1984) 
(1 : 16) 
Waterbuck (Kobus ellipsiprymnus)-Harnblin and Hedger (1984) 
(1:45 to 1 : 1024) 
Heuschele ( 1982) 
Defassa waterbuck (Kobus defassa)-Hamblin and Hedger (1984) 
(1:128 to 1:708) 
Heuschele et al. (1984a) 
(1:8 to 1:16) 
Uganda kob (Kobus kob)- Heuschele et al. (1984a) 
(1:2 to 1:12) 
Re dune a 
Reedbuck (Redunca arundinum)-Hamblin and Hedger (1984) 
(1:90 to 1:1024) 
Antilopinae 
Aepyceros 
Impala (Aepyceros melampus) -Reid et al. (1975) 
Barnard (1985) 
Hamblin and Hedger (1984) 
(1:4 to 1:22) 
Heuschele et al. (1984a) 
(1:2 to 1:48) 
Antidorcas 
Springbok (Antidorcas marsupialis)-Heuschele et al. ( 1984a) 




Blackbuck (Antilope cervicapra)-Heuschele (1982) 
Gazella 
Dorcas gazelle (Gazella dorcas)-Heuschele et al . (1984a) 
(1:4 to 1:8) 
Roosevelts gazelle 
(G. granti roosevelti)-Heuschele et al. (1984a) 
(1:2 to 1:4) 
Persian gazelle (Gazella subgutturosa)-Heuschele (1982) 
Capri nae 
Ammotragus 
Aoudad/Barbary sheep (A. lervia)-Heuschele et al . (1984a) 
(1:16 to 1:256) 
Capra 
Domestic goat (Capra hircus)-Heuschele et al. (1984a) 
(1:3 to 1:16) 
Turkomen markhor (Capra falconeri)-Heuschele et al. (1984a) 
(1:3 to 1:32) 
Alpine ibex (Capra ibex ibex)-Heuschele et al. (1984a) 
(1:2 to 1:8) 
Nubian ibex (Capra ibex nubiana)-Heuschele et al. (1984a) 
(1:2 to 1:24) 
West caucasian tur (C. ibex caucasica)-Heuschele et al. (1984a) 
(1:2 to 1:8) 
Cretan goat (Capra aegagrus cretensis)-Heuschele et al . (1984a) 
(1:2 to 1:8) 
Hemitragus 
Nilgiri tahr (Hemitragus hylocrius)- Heuschele (1982) 
Himalayan tahr (Hemitragus jemlahicus)-Heuschele et al. (1984a ) 
(1:2 to 1:40) 
Ovis 
Afghan urial (Ovis cycloceros)-Heuschele (1982) 
Bighorn sheep (Ovis canadensis)-Heuschele et al. (1984a) 
(1:2 to 1:4) 
Dall sheep (Ovis dalli) -Heuschele et al. (1984a) 
(1:2 to 1:8) 
Domestic sheep (Ovis aries)-Kalunda et al. (198la ) 
(1:4 to 1:16) 
European mouflon (Ovis musimon) - Heuschele et al. (1984a) 
(1:2 to 1:16) 
Rupicapra 
Chamois (Rupicapra rupicapra)-Heuschele et al. (1984a) 
(1:2 to 1 : 8) 
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APPENDIX V 
Table 12. Previously reported antigenic relationships between alcelaphine herpesvirus- 1 
(AHV-1) and other herpesviruses as detected by the indirect immunof luorescence assay 
Viral Antigensa 
AHV-1 BHV-1 BHV-2 BHV-3 Penn PHV-1 





Rossiter et al. (1977) 512 512 Nob 8 8 8 ND ND <8 
Rossiter et al . (1977) 2048 1024 ND 8 8 8 ND ND <8 
Rossiter (1983) 1024 ND ND <8 <8 <8 ND ND <8 
C500 
Rossiter et al. ( 1977) 512 512 ND 8 8 8 ND ND <8 
Rossiter et al. (1977) 256 256 ND 8 <8 <8 ND ND <8 
IG30359 
Osorio et al. (1985) ND ND 160 <5 <5 10 <5 40 ND 
SGA 
Rossiter (1983) 256 ND ND 8 32 <8 ND ND <8 
Rossiter (1983) 32 ND ND <8 <8 <8 ND ND <8 
Rossiter (1983) 512 ND ND <8 <8 8 ND ND <8 
BHV-1 
Rossiter et al. (1977) 16 8 ND 512 8 <8 ND ND <8 
Rossiter et al. (1977) 64 16 ND 2048 8 <8 ND ND 16 
Heuschele ( 1982) 40 ND ND ND ND ND ND ND ND 
Osorio et al. (1985) ND ND <5 160 <5 <5 <5 <5 ND 
BHV-2 
Rossiter et al. (1977) <8 <8 ND <8 512 <8 ND ND <8 
Rossiter et al. (1977) <8 <8 ND <8 1024 <8 ND ND <8 
Heuschele (1982) 80 ND ND ND ND ND ND ND ND 
Osorio et al. (1985) ND ND <5 <5 80 <5 <5 <5 ND 
BHV-3 
Rossiter et al. (1977) 128 32 ND <8 <8 2048 ND ND 
Heuschele (1982) 80 ND ND ND ND ND ND ND 
Osorio et al. (1985) ND ND <5 <5 <5 160 320 20 
Penn 47 
Osorio et al. (1985) ND ND 20 <5 <5 20 20 160 
PHV-1 
Rossiter et al. (1977) <8 <8 ND <8 <8 <8 ND ND 
Rossiter et al. (1977) <8 <8 ND <8 8 8 ND ND 
aAHV-1 (WCll, C500, IG30359) - wildebeest -derived malignant catarrhal fever; 
SGA - sheep-goat-associated malignant catarrhal fever; BHV-1 (IBR) - infectious bovine 
rhinotracheitis; BHV-2 (BHM) - bovine herpes mammillitis; 
BHV-3 (DN599, Movar 33/63) - movar group bovine herpesvirus; Penn 47 - cell-associated 
herpesvirus isolated from cow with lymphosarcoma-Van der Maaten and Boothe (1972) 
PHV-1 (PRV) - pseudorabies. 









Species with Alcelaphine Herpesvirus-1 Antibodies Detected 








Reeves muntj ac (Muntiacus reevesi)-Heuschele (1982) 
Cervinae 
Cervus 
Axis deer (Cervus axis)-Heuschel e (1982) 
European fallow deer (Cervus dama)-Heuschele (1982) 
Barasingha (Cervus duvauceli)-Heuschele (1982) 
European red deer (Cervus elaphus)-Ashton (1982) 
Altai wapiti (Cervus elaphus sibiricus)-Heuschele (1982) 
Elds deer (Cervus eldi thamin)-Heuschele (1982) 
Formosan sika deer (Cervus nippon taiwanus)-Heuschele (1982) 
Ashton (1982) 
Tonkin sika deer (Cervus nippon)-Heuschele ( 1982) 
Indian hog deer (Cervus porcinus) -Heuschele (1982) 
Elaphurus 








American bison (Bison bison)-Heuschele (1982) 
Ashton (1982) 
European bisonjWisent (Bison bonasus) -Ashton (1982) 
Bos 
Indian gaur (Bos gaurus)-Heuschele (1982) 
Domestic cattle (Bos taurus)-Rossiter et al. ( 1980) 
Boselaphus 
Nilgai (Boselaphus tragocamelus)-Heuschele (1982) 
Ashton (1982) 
Syncerus 
Cape buffalo (Syncerus caffer caffer)- Heuschele (1982) 
Ashton (1982) 
Taurotragus 
Eland (Taurotragus oryx)-Heuschele (1982) 
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Tragelaphus 
Sitatunga (Tragelaphus spekei)-Heuschele (1982) 
Ashton (1982) 
Ramsay et al. (1982) 
Greater kudu (Tragelaphus strepsiceros)-Heuschele (1982) 
Hippotraginae 
Addax 
Addax (Addax nasomaculatus)-Heuschele (1982) 
Ramsay et al. (1982) 
Hippotragus 
Roan antelope (Hippotragus eguinus)-Heuschele (1982) 
Oryx 
Scimitar-horned oryx (Oryx dammah)-Heuschele (1982) 
Ashton (1982) 
Gemsbok (Oryx gazella gazella)-Heuschele (1982) 
Fringe-eared oryx (Oryx gazella callotis)-Heuschele (1982) 
Arabian oryx (Oryx leucoryx)-Heuschele (1982) 
Alcelaphinae 
Alcelaphus 
Cape hartebeest (A. buselaphus caama)-Heuschele (1982) 
Ramsay et al. (1982) 
Connochaetes 
Whitetailed wildebeest (C. gnou)-Heuschele (1982) 
Ramsay et al. (1982) 




(C. taurinus albojubatus)-Heuschele (1982) 
Damaliscus 
Topi (Damaliscus lunatus jimela)-Heuschele (1982) 
Reduncinae 
Kobus 
Ellipsen waterbuck (Kobus ellipsiprymnus)-Heuschele (1982) 
Defassa waterbuck (Kobus ellipsiprymnus)-Heuschele (1982) 
Uganda kob (Kobus kob)-Heuschele (1982) 
Antilopinae 
Aepyceros 
Impala (Aepyceros melampus)-Heuschele (1982) 
Antidorcas 
Springbok (Antidorcas marsupialis)-Heuschele (1982) 
Anti lope 
Blackbuck (Antilope cervicapra)-Heuschele (1982) 
Gazella 
Addra gazelle (Gazella dama dama)-Heuschele (1982) 
Dorcas gazelle (Gazella dorcas)-Heuschele (1982) 
Grants gazelle (Gazella granti)-Heuschele (1982) 
Slender horned gazelle (Gazella leptoceros)-Heuschele (1982) 
Persian gazelle (Gazella subgutturosa)-Heuschele (1982) 
Ourebia 




Domestic goat (Capra hircus)-Heuschele (1982) 
Markhor (Capra falconeri)-Heuschele (1982) 
Nubian ibex (Capra ibex nubiana)-Heuschele (1982) 
Ramsay et al. (1982) 
Siberian ibex (Capra ibex sibirica)-Heuschele (1982) 
Cretan wild goat (Capra aegagrus cretensis) -Heuschele (1982) 
African pygmy goat (Capra hircus)-Heuschele (1982) 
Hemitragus 
Nilgiri tahr (Hemitragus hylocrius)-Heuschele (1982) 
Himalayan tahr (Hemitragus j emlahicus) -Heuschele (1982) 
Ovibos 
Musk ox (Ovibos moschatus)-Heuschele (1982) 
Ash ton (1982) 
Ovis 
Bighorn sheep (Ovis canadensis)-Heuschele (1982) 
Domestic sheep (Ovis aries)-Rossiter (198la) 
Heuschele (1982) 
American mouflon (Ovis gmelini)-Heuschele (1982) 
European mouflon (Ovis musimon)-Heuschele (1982) 
Rupicapra 
Chamois (Rupicapra rupicapra)- Ramsay et al. (1982) 
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APPENDIX VII 
Solutions and Buffers 
40% Sucrose Solution (0.2M PBS ): 
Na2HP04 2.38 g/100 ml distilled water 
NaH2P04 0.44 g/100 ml distilled water 
NaCl 0 .8S g/100 ml distilled water 
q.s. to 100 ml with distilled water and 
filter sterilize (0.22 µm) 
add s ucrose 40 g/100 ml 0.2M PBS 
Mix and store at 4C . 
Antigen Solubiliza tion Buffer (Tris/Glycine/Triton X-100): 
Tris base 0 .61 g/L distilled water (0.00SM) 
Gl ycine 0.7S g/L distilled water (O.OlM) 
Triton X-100 1 .0 ml/ 100 ml distilled water (1%) 
Adjust pH to 8.9 prior to use. 
Borate Buffer: 
NaOH 2 g 
H3B03 9 g 
q.s. to 1 liter with distilled water 
Adjust pH to 8.6 prior to use . 
Antigen Coating Buffer : 
Na2C03 l .S9 g 
NaHC03 2.93 g 
q.s. to 1 liter with distilled water 
Store at 4C. Adjust pH to 9.6 using SM NaOH. 
ELISA Wash Solution: 
phosphate buffered saline O.OlM (pH 7.2) 1 liter 
tween-20 0.2S ml 
Stir mixture well prior to use. 
ABTS Substrate Solution: 
1. Substrate diluent (c i tric acid solution) 
citric acid 10.Sl g (0 .0SM) 
distilled water 1 liter 
Store at 4C. Adjust pH of test volume (10 ml/plate) to 4.0 
using SM NaOH prior to use. 
2 . Stock SO% H202 - diluted l :SO with distilled water . 
Add 0.04 ml diluted H202/lO ml substrate diluent. 
3. Stock ABTS solution 
(2-2 ' Azino-di-(3-ethylbenzthi azaline-6-sulfonic acid) 
S48.7 mg/2S ml distilled water (40mM) 
Store at 4C in sealed amber bottle. 
Add stock ABTS solution 0.1 ml/ 10 ml s ubstrate diluent. 
Mix substrate by gent l y swirling the mixture 
